<SEC-DOCUMENT>0001140361-26-011145.txt : 20260325
<SEC-HEADER>0001140361-26-011145.hdr.sgml : 20260325
<ACCEPTANCE-DATETIME>20260325171119
ACCESSION NUMBER:		0001140361-26-011145
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20260325
DATE AS OF CHANGE:		20260325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRC Inc.
		CENTRAL INDEX KEY:			0001891101
		STANDARD INDUSTRIAL CLASSIFICATION:	BEVERAGES [2080]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				873277812
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-294604
		FILM NUMBER:		26793469

	BUSINESS ADDRESS:	
		STREET 1:		3131 W. 2210 S., SUITE C
		CITY:			WEST VALLEY CITY
		STATE:			UT
		ZIP:			84119
		BUSINESS PHONE:		(801) 874-1189

	MAIL ADDRESS:	
		STREET 1:		3131 W. 2210 S., SUITE C
		CITY:			WEST VALLEY CITY
		STATE:			UT
		ZIP:			84119
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ny20068427x1_s3.htm
<DESCRIPTION>S-3
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 540pt;"><a name="ny20068427x1_s3_100-regcov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 26.2pt; text-align: center;">As filed with the Securities and Exchange Commission on March&#160;25, 2026 </div><div class="BRDSX_regno" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: right;">No. 333-&#8195;&#8195; </div></div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 9.5pt; text-align: center;">SECURITIES AND EXCHANGE COMMISSION<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt;">WASHINGTON, D.C. 20549 </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 5.25pt;"> </div></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 8.5pt; text-align: center;">FORM S-3<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt;">REGISTRATION STATEMENT </font><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt;">UNDER </font><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt;">THE SECURITIES ACT OF 1933</font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 5.25pt;"> </div></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 24pt; font-weight: bold; margin-top: 10.5pt; text-align: center;">BRC Inc. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 10pt;"><font style="font-size: 10pt; font-weight: normal;">(Exact name of registrant as specified in its charter) </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 5.25pt;"> </div></div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -2pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 172pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Delaware</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">2080</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">82-3277812</div></td></tr><tr><td style="width: 172pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(State or other jurisdiction of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">incorporation or organization)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Primary Standard Industrial <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Classification Code Number)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(I.R.S. Employer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Identification No.)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 3.5pt; text-align: center;">3131 W. 2210 S., Suite C<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: center;">West Valley City, UT 84119<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(801) 847-1189 </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3.49pt; text-align: center;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices) </div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 5.25pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 5.5pt; text-align: center;">Chris Mondzelewski <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Chief Executive Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: center;">BRC Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: center;">3131 W. 2210 S., Suite C<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: center;">West Valley City, UT 84119 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(801) 847-1189 </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; text-align: center;">(Name, address, including zip code, and telephone number, including area code, of agent for service) </div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-style: italic; font-weight: bold; margin-top: 7pt; text-align: center;">Copy to:<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: normal;">Elizabeth A. Razzano, Esq.</font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: normal;">Paul Hastings LLP</font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: normal;">1117 S. California Avenue</font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: normal;">Palo Alto, CA 94304</font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: normal;">(650) 320-1800</font><font style="font-style: normal; font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the only securities being registered on this Form&#160;are being offered pursuant to dividend or interest reinvestment plans, please check the following box: <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If any of the securities being registered on this Form&#160;are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, check the following box: &#x2612; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If this Form&#160;is filed to registered additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If this Form&#160;is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If this Form&#160;is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(c) under the Securities Act, check the following box. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -2pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 216pt; padding-bottom: 0.35pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Large accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.35pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.8pt; font-family: Arial, Helvetica, sans-serif;">&#x2610;</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; padding-bottom: 0.35pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.35pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2612; </div></td></tr><tr><td style="width: 216pt; padding-bottom: 0.35pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.31pt; padding-bottom: 0.35pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.8pt; font-family: Arial, Helvetica, sans-serif;">&#x2610;</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; padding-bottom: 0.35pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Smaller reporting company</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.31pt; padding-bottom: 0.35pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.8pt; font-family: Arial, Helvetica, sans-serif;">&#x2610;</font><font style="font-size: 9.8pt;"> </font></div></td></tr><tr><td style="width: 216pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Emerging growth company</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2612;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.7pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.7pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.8pt; font-weight: bold; margin-top: 3pt; margin-left: 0pt; text-align: justify;">The registrant hereby amends this Registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section&#160;8(a), may determine.<font style="font-weight: normal;"> </font></div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 1-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20068427x1_s3_101-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #FC0014; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><div style="font-family: Arial, Helvetica, sans-serif; text-align: left; margin-bottom: 12pt;">The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where such offer or sale is not permitted. </div>SUBJECT TO COMPLETION, DATED MARCH 25, 2026<font style="color: #000000;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">PRELIMINARY PROSPECTUS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; text-align: center;"><img style="height: 60px; width: 234px;" src="logo_brc1.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 5pt; text-align: center;">BRC INC.<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 14pt; text-align: center;">$500,000,000 <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class&#160;A Common Stock <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 0pt; text-align: center;">Subscription Rights <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">This prospectus relates to the offer and sale by us, from time to time and in one or more transactions, of up to $500,000,000 in the aggregate of any combination of the securities identified above from time to time in one or more offerings, either individually or in combination with other securities. The preferred stock, subscription rights, warrants and units may be exercisable or exchangeable for Class&#160;A Common Stock or preferred stock or other securities of ours. This prospectus provides you with a general description of the securities covered hereby and the general manner in which we may offer or sell the securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">We will provide specific terms of any offering by the Company in a supplement to this prospectus. Any prospectus supplement may also add, update or change information contained in this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus, prospectus supplement and any related free writing prospectuses may also add, update or change information contained in this prospectus with respect to that offering. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">Our registration of the securities covered by this prospectus does not mean that either we will issue, offer or sell, as applicable, any of the securities. We may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices. We provide more information about how we may sell the shares in the section entitled &#8220;<font style="font-style: italic;">Plan of Distribution</font>.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">You should carefully read this prospectus and the applicable prospectus supplement as well as the documents incorporated or deemed to be incorporated by reference in this prospectus before you purchase any of the securities offered hereby. Our Class&#160;A Common Stock trades on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the ticker symbol &#8220;BRCC.&#8221; On March 23, 2026, the closing sale price of our Class&#160;A Common Stock as reported by NYSE was $0.84 per share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">We are an &#8220;emerging growth company,&#8221; as that term is defined under the federal securities laws and, as such, are subject to certain reduced public company reporting requirements and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings with the Securities and Exchange Commission. See &#8220;<font style="font-style: italic;">Prospectus Summary &#8211; Implications of Being an Emerging Growth Company</font>&#8221;. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; on page <a href="#tRF">9</a> of this prospectus and contained in the applicable prospectus supplement and in any free writing prospectuses we have authorized for use in connection with a specific offering, and under similar headings in the documents that are incorporated by reference into this prospectus.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">This prospectus may not be used to consummate a sale of securities unless accompanied by a prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">The securities may be offered and sold from time to time, through agents designated by us or to or through underwriters, brokers or dealers, on a continuous or delayed basis. For additional information on the methods of sale, you should refer to the section entitled &#8220;<font style="font-style: italic;">Plan of Distribution</font>&#8221; in this prospectus. If any agents, underwriters, brokers or dealers are involved in the sale of any securities with respect to which this prospectus is being delivered, the names of such agents, underwriters, brokers or dealers and any applicable fees, commissions, discounts and over allotment options will be set forth in a prospectus supplement or a related free writing prospectus. When applicable, the price to the public of such securities and the net proceeds we expect to receive from such sale, if any, will also be set forth in a prospectus supplement or a related free writing prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 11pt;">Neither the Securities and Exchange Commission nor any other state securities commission has approved or disapproved of these securities or passed on the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; text-align: center;">The date of this prospectus is &#8195;&#8195;&#8195;&#8195;, 2026.</div></div></div></div>
<!--End Page 2-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_102-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS</div><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.44pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 432pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page </div></td></tr><tr><td style="width: 432pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tICR">INFORMATION INCORPORATED BY REFERENCE<font style="padding-left: 1.3pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tICR"><font style="padding-left: 5pt;">1</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tABT">ABOUT THIS PROSPECTUS<font style="padding-left: 0.99pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tABT"><font style="padding-left: 5pt;">2</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS<font style="padding-left: 3.52pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tFLS"><font style="padding-left: 5pt;">3</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPS">PROSPECTUS SUMMARY<font style="padding-left: 3.67pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tPS"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 0.15pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">9</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUSE">USE OF PROCEEDS<font style="padding-left: 1.73pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tUSE">10</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">DESCRIPTION OF CAPITAL STOCK<font style="padding-left: 0.6pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOC"><font style="padding-left: 0.37pt;">11</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOW">DESCRIPTION OF WARRANTS<font style="padding-left: 1.93pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOW">18</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOS">DESCRIPTION OF SUBSCRIPTION RIGHTS<font style="padding-left: 2.04pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOS">20</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOU">DESCRIPTION OF UNITS<font style="padding-left: 2.3pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOU">21</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">PLAN OF DISTRIBUTION<font style="padding-left: 0.64pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tPOD">22</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tMUS">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES<font style="padding-left: 4.86pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tMUS">24</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 4.05pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tLM">29</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXP">EXPERTS<font style="padding-left: 1.77pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tEXP">29</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 2.99pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tWYC">29</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 3-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_103-info_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tICR"><!--Anchor--></a>INFORMATION INCORPORATED BY REFERENCE </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This registration statement incorporates by reference important business and financial information about the Company that is not included in or delivered with this document. The information incorporated by reference is considered to be part of this prospectus, and the Securities and Exchange Commission (the &#8220;SEC&#8221;) allows us to &#8220;incorporate by reference&#8221; the information we file with it, which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus. Any statement contained in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in or omitted from this prospectus or any accompanying prospectus supplement, or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus. We incorporate by reference: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2025, filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001891101/000189110126000022/brcc-20251231.htm">March&#160;2, 2026</a> (our&#160;&#8220;Annual Report&#8221;); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Our Current Report on Form&#160;8-K, filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1891101/000189110126000005/brcc-20260211.htm">February&#160;13, 2026</a>; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Our Current Reports on Form&#160;8-K/A filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1891101/000189110126000013/brcc-20250411.htm">February&#160;23, 2026 (filed at 16:51:32 EST)</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1891101/000189110126000014/brcc-20250915.htm">February&#160;23, 2026 (filed at 16:51:58 EST)</a>; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The description of our registered securities filed as <a href="https://www.sec.gov/Archives/edgar/data/1891101/000110465922034159/brrc-20220202xex4d5.htm">Exhibit&#160;4.5</a> to our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We also incorporate by reference into this prospectus any further filings we make with the SEC under Sections&#160;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) (other than portions of those made pursuant to Item&#160;2.02 or Item&#160;7.01 of Form&#160;8-K or other information &#8220;furnished&#8221; and not filed with the SEC), including all filings filed after the date hereof and prior to the completion of an offering of securities under this prospectus and the information specifically incorporated by reference into our annual reports on Form&#160;10-K from our Definitive Proxy Statements on Schedule 14A (other than information furnished rather than filed) filed with the SEC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have filed with the SEC this registration statement under the Securities Act of 1933, as amended (the&#160;&#8220;Securities Act&#8221;), covering the shares of Class&#160;A Common Stock to be offered and sold by this prospectus and any applicable prospectus supplement. This prospectus does not contain all of the information included in the registration statement, some of which is contained in exhibits to the registration statement. The registration statement, including the exhibits, can be read at the SEC website referred to below under &#8220;<font style="font-style: italic;">Where You Can Find More Information</font>.&#8221; Any statement made in this prospectus or any prospectus supplement concerning the contents of any contract, agreement or other document is only a summary of the actual contract, agreement or other document. If we have filed any contract, document, agreement or other document as an exhibit to the registration statement or any other document incorporated herein by reference, you should read the exhibit for a more complete understanding of the document or matter involved. Each statement regarding a contract, agreement or other document is qualified in its entirety by reference to the actual document. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our filings with the SEC, including Annual Reports on Form&#160;10-K, Quarterly Reports on Form&#160;10-Q, Current Reports on Form&#160;8-K and amendments to those reports, are available free of charge on our website at www.blackriflecoffee.com as soon as reasonably practicable after they are filed with, or furnished to, the SEC. Our website and the information contained on that site, or connected to that site, are not incorporated into and are not a part of this prospectus. Copies of all documents incorporated by reference in this prospectus, other than exhibits to those documents unless such exhibits are specially incorporated by reference in this prospectus, will be provided at no cost to each person, including any beneficial owner, who receives a copy of this prospectus on the written or oral request of that person made to: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;">BRC Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3131 W. 2210 S., Suite C<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">West Valley City, UT 84119 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(801) 847-1189 </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 4-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_104-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tABT"><!--Anchor--></a>ABOUT THIS PROSPECTUS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus is part of a registration statement that we filed with the SEC using the &#8220;shelf&#8221; registration process. Under this shelf registration process, we may, from time to time, in one or more offerings, sell securities up to a total dollar amount of $500,000,000 as described in this prospectus. This prospectus provides you with a general description of the securities we may offer. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each time we offer to sell securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in any documents that we have incorporated by reference into this prospectus. To the extent that any statement that we make in a prospectus supplement is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded by those made in a prospectus supplement. We urge you to read carefully this prospectus, any applicable prospectus supplement and any related free writing prospectus we have authorized for use in connection with a specific offering, together with the information incorporated herein by reference as described under the headings &#8220;<font style="font-style: italic;">Where You Can Find Additional Information</font>&#8221; and &#8220;<font style="font-style: italic;">Incorporation of Certain Information by Reference</font>,&#8221; before buying any of the securities being offered. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus may not be used to consummate a sale of securities unless it is accompanied by a prospectus supplement.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have not authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any applicable prospectus supplement or any related free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You should not assume that the information appearing in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate on any date subsequent to the date set forth on the front of the document or that any information we have incorporated by reference herein or therein is correct on any date subsequent to the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, the applicable prospectus supplement or any related free writing prospectus, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those dates. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the section entitled &#8220;<font style="font-style: italic;">Where You Can Find Additional Information</font>.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For investors outside the United States: neither we nor any of our respective affiliates have done anything that would permit this offering or the possession or distribution of this prospectus in any jurisdiction where action for those purposes is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, this offering of securities and the distribution of this prospectus outside the United States. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless the context requires otherwise, references in this prospectus to &#8220;Black Rifle Coffee Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to BRC Inc., a Delaware public benefit corporation, and its consolidated subsidiaries, unless otherwise specified. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 5-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_105-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tFLS"><!--Anchor--></a>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus and the information incorporated by reference herein includes statements that express the Company&#8217;s opinions, expectations, hopes, beliefs, plans, intentions, objectives, strategies, assumptions or projections regarding future events or future results of operations or financial condition and therefore are, or may be deemed to be, &#8220;forward-looking statements.&#8221; The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements appear in a number of places throughout this prospectus and the information incorporated by reference herein and include statements regarding the Company&#8217;s intentions, beliefs or current expectations concerning, among other things, the Company&#8217;s results of operations, financial condition, liquidity, prospects, growth, strategies, future market conditions or economic performance and developments in the capital and credit markets and expected future financial performance, the markets in which the Company operates as well as any information concerning possible or assumed future results of operations of the Company. Such forward-looking statements are based on information available as of the date of this prospectus and management&#8217;s expectations, beliefs and forecasts concerning future events impacting the Company. Factors that may cause such forward-looking statements to differ from actual results include, but are not limited to: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Competition and our ability to grow, manage sustainable expansion, and retain key employees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Failure to compete effectively with other producers, distributors and retailers of coffee and energy drinks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Our limited operating history, which may hinder the successful execution of strategic initiatives and make it difficult to assess future risks and challenges; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Challenges in managing rapid growth, inventory needs, and relationships with key business partners; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Inability to raise additional capital necessary for business development; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Failure to achieve or sustain long-term profitability; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Inability to effectively manage debt obligations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Failure to maximize the value of assets received through bartering transactions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Negative publicity affecting our brand, reputation, or that of key employees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Failure to uphold our position as a supportive member of the military, Veteran and first-responder communities, or other factors negatively affecting brand perception; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Inability to establish and maintain strong brand recognition through intellectual property or other means; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Shifts in consumer spending, lack of interest in new products or changes in brand perception upon evolving consumer preferences and tastes, including due to shifts in demographic or health-and-wellness trends, reduction in discretionary spending and price increases, and our ability to anticipate or react to these changes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Price changes that are insufficient to offset cost increases; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Unsuccessful marketing campaigns that incur costs without attracting new customers or realizing higher revenue; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Failure to attract new customers or retain existing customers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Risks associated with reliance on social media platforms, including dependence on third-party platforms for marketing and engagement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Declining performance of the Direct-to-Consumer (&#8220;DTC&#8221;) revenue channel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Inability to effectively manage or scale distribution through Wholesale business partners, particularly key Wholesale partners; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Failure to manage supply chain operations effectively, including inaccurate forecasting of raw material and co-manufacturing requirements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Loss of one or more co-manufacturers or production delays, quality issues, or labor-related disruptions affecting manufacturing output; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 6-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_105-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Supply chain disruptions or failures by third-party suppliers and logistics service-providers to deliver coffee, store supplies, ready-to-drink (&#8220;RTD&#8221;) beverage ingredients, or merchandise, including disruptions caused by external factors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Ongoing risks related to supply chain volatility and reliability, including tariffs, political and climate risks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Fluctuations in the market for high-quality coffee beans and other key commodities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Unpredictable changes in the cost and availability of labor, raw materials, equipment, transportation, or shipping; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Failure to successfully improve profitability of existing Outpost Retail Stores (&#8220;Outposts&#8221;), including challenges or delays with the implementation of operational and strategic changes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Risks related to long-term, non-cancelable lease obligations and other real estate-related concerns; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Inability of franchise partners to successfully operate and manage their franchise locations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Failure to maintain high-quality customer experiences for retail partners and end users, including production defects or issues caused by co-manufacturers that negatively impact product quality and brand reputation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Failure to comply with food safety regulations or maintain product quality standards; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Difficulties in successfully expanding into new domestic and international markets; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Failure to comply with federal, state, and local laws and regulations, or inability to prevail in civil litigation matters; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Risks related to potential unionization of employees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Failure to execute our operational improvement plan (&#8220;Operational Improvement Plan&#8221;) to reduce costs and improve efficiency of certain company-wide functions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Failure to protect against cybersecurity threats, software vulnerabilities, or hardware security risks; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Other risks and uncertainties indicated in this prospectus and the information incorporated by reference herein. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The forward-looking statements contained in this prospectus and the information incorporated by reference herein are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under &#8220;Item&#160;1A. Risk Factors&#8221; in our Annual Report and those described under the heading &#8220;<font style="font-style: italic;">Risk Factors</font>.&#8221; Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We will not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 7-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20068427x1_s3_106-summary_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPS"><!--Anchor--></a>PROSPECTUS SUMMARY </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary highlights selected information appearing elsewhere in this prospectus. Because it is a summary, it may not contain all of the information that may be important to you. To understand this offering fully, you should read this entire prospectus carefully, including the information set forth under the heading &#8220;Risk Factors&#8221; and our consolidated financial statements incorporated herein by reference.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 20pt; text-align: left;">Company Overview </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Black Rifle Coffee Company is a Veteran-founded and led premium coffee, and energy drink, company operating through one reportable segment composed of three primary channels: Wholesale, DTC, and Outposts. We leverage in-house media and content creation to support brand awareness, customer engagement, and community building. Founded in 2014 by U.S. Army Veteran Evan Hafer, Black Rifle Coffee began with a one-pound coffee roaster in a garage, where Hafer personally roasted, packaged, and shipped coffee directly to consumers. Today, we have grown into a widely recognized and nationally distributed brand steadfast in its commitment to supporting active-duty military, Veterans, first responders, and others who share our values. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Black Rifle Coffee operates out of offices in West Valley City, Utah; San Antonio, Texas; and Nashville, Tennessee, with a manufacturing facility in Manchester, Tennessee. Our product offerings have expanded beyond traditional roast coffee to include single-serve coffee and ready-to-drink coffee products, as well as Black Rifle Energy, a ready-to-drink energy beverage launched in late 2024. In addition, we offer Black Rifle branded apparel, coffee brewing equipment, and outdoor and lifestyle gear designed to extend brand engagement and customer loyalty. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 20pt; text-align: left;">Our Mission and Community </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our mission at Black Rifle Coffee Company is to serve premium coffee and energy beverages and provide proprietary content to active-duty military, Veterans, first responders, and others who share our values. Founded and led by combat Veterans of the Global War on Terror, we are a mission-driven company committed to delivering quality products while giving back to the communities we serve. This dedication is reflected in our recruitment and hiring practices, charitable donations, and storytelling through our media channels. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As a public benefit corporation, Black Rifle Coffee Company balances profitability with purpose. Our public benefit purpose is to support active duty military members, Veterans, and first-responders, including underserved populations within those communities. We achieve this through objectives such as: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Creating meaningful post-service career opportunities for Veterans, first responders, and their families. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Supporting charities focused on mental health and other critical needs within these communities. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Inspiring Veterans to pursue entrepreneurship through select programs and charitable support. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Providing quality products and content that resonate with these audiences. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A significant factor in our success is the work ethic and discipline of our Veteran employees. We are committed to hiring Veterans and military spouses, supporting their transition from military service to private industry. This dedication fosters a strong, cohesive culture at Black Rifle Coffee Company, and we seek to maintain Veterans and military spouses as a meaningful portion of our workforce. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our corporate giving is strengthened through direct cash and in-kind donations to charities aligned with our public benefit purpose, providing direct support to individuals, charities, and organizations aligned with our mission to serve those who serve. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 20pt; text-align: left;">Our Business </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are a digitally native brand with an established omnichannel business model, operating through one reportable segment composed of three primary channels: Wholesale, DTC and Outposts. Each channel plays a distinct role in reaching our customers, building our community, and growing our brand. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In our Wholesale channel, we sell packaged coffee and our RTD beverages through leading Food, Drug, and Mass (&#8220;FDM&#8221;) retailers such as Walmart, Sam&#8217;s Club, regional and national grocery chains, and convenience stores, such as 7-Eleven, Casey&#8217;s General Store, and Circle K. Additionally, our coffee, apparel, and gear are sold through specialty retailers like Bass Pro Shops, Scheels, and Ace Hardware. In 2025, the Wholesale channel generated $258.0&#160;million in </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 8-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20068427x1_s3_106-summary_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">sales, compared to $245.0&#160;million in 2024. We have prioritized growth in this channel by expanding distribution in grocery stores, club stores, convenience stores, and specialty retailers, positioning the Wholesale channel as a key driver of future revenue. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our DTC platform has been the foundation of our business since the inception of the company and launch of www.blackriflecoffee.com. This channel enabled us to establish brand awareness and scale as a recognizable beverage brand in the United States. Through this channel, we engage directly with customers and obtain insight into consumer preferences. The DTC channel includes our subscription-based Coffee Club, through which customers can receive ground, whole bean, single-serve coffee, or apparel delivered to their home or office on a customizable schedule. As of December&#160;31, 2025, the Coffee Club served approximately 159,900 active subscribers. In 2025, DTC sales totaled $117.6&#160;million, compared to $123.8&#160;million in 2024, reflecting a 5% decline primarily due to consumer purchasing behavior shifting toward retail channels and reallocation of resources in order to grow the Wholesale channel. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Outposts offer a company-operated and franchised coffee shop experience, featuring freshly brewed coffee, Black Rifle Coffee merchandise, and a community oriented environment. Since opening the first Outpost in San Antonio, Texas, in 2020, we have expanded to operate 17 company-owned Outposts and 18 franchised locations across ten states, including Texas, Utah, and Tennessee. In 2025, Outpost sales totaled $22.6&#160;million, a decline from $22.7&#160;million in 2024. While new unit growth in this channel is currently limited, we will continue to evaluate the role of this channel within our broader growth strategy, while prioritizing capital allocation toward growth in the Wholesale channel. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We create proprietary digital and social media content designed to strengthen our connection with the Black Rifle Coffee community. Guided by a three-pronged strategy&#8212;Inform, Inspire, and Entertain&#8212;we use content to educate consumers on our products and brand, including insights into our roasting processes and premium offerings. Through brand-focused storytelling, we highlight the experiences of Veterans, first responders, and everyday heroes who embody our mission. At the same time, we captivate and entertain with humor, creativity, and engaging formats that resonate deeply with our loyal and passionate customer base. This comprehensive approach reflects our core values while fostering lasting brand loyalty and recognition. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to media content, we continue to grow through strategic partnerships and collaborations that amplify our brand and extend our reach. These initiatives include partnerships with social media influencers and high-profile sports organizations to connect with new and existing audiences. For instance, in July&#160;2022, we announced a partnership with the Dallas Cowboys, featuring product placement at AT&amp;T Stadium. In February&#160;2024, we entered into a three-year marketing partnership with the UFC, which includes brand visibility across UFC platforms and events. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These partnerships, combined with our integrated media and marketing strategy, help us build connections with our customers, drive brand loyalty, and differentiate Black Rifle Coffee in a competitive market. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Corporate Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our principal executive offices are located at 3131 W. 2210 S., Suite C, West Valley City, UT 84119. Our telephone number at that address is (801) 847-1189. Our website address is <font style="font-style: italic;">www.blackriflecoffee.com</font>. Our website is included in this prospectus as an inactive textual reference only. Except for the documents specifically incorporated by reference into this prospectus, our website and the information contained on our website are not a part of this prospectus or any applicable prospectus supplement, and you should not rely on any such information in making your decision whether to invest in the securities covered by this prospectus. We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC. You may obtain any of the documents filed by us with the SEC at no cost from the SEC&#8217;s website at <font style="font-style: italic;">http://www.sec.gov.</font> </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 9-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20068427x1_s3_106-summary_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Description of Securities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may offer shares of our Class&#160;A Common Stock and preferred stock, and warrants or subscription rights to purchase any of such securities, either individually or in combination with other securities or in units, up to a total aggregate offering price of $500,000,000 from time to time in one or more offerings under this prospectus, together with the applicable prospectus supplement and any related free writing prospectus, at prices and on terms to be determined by market conditions at the time of any relevant offering. This prospectus provides you with a general description of the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent applicable: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">designation or classification; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">aggregate offering price; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">times of payment of dividends, if any; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">redemption, conversion, exercise or exchange, if any; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ranking; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">restrictive covenants, if any; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">voting or other rights, if any; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">conversion or exchange prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion or exchange prices or rates and in the securities or other property receivable upon conversion or exchange; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">material or special U.S. federal income tax considerations, if any. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The applicable prospectus supplement and any related free writing prospectus that we may authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in the documents we have incorporated by reference. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The securities may be offered directly to investors from time to time, through agents designated by us or to or through agents, underwriters, brokers or dealers. We, and our agents, underwriters, brokers or dealers, reserve the right to accept or reject all or part of any proposed purchase of securities. If we do offer securities to or through agents, underwriters, brokers or dealers, we will include in the applicable prospectus supplement: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the names of those agents, underwriters, brokers or dealers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">applicable fees, discounts and commissions to be paid to them; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">details regarding over-allotment or other options to purchase additional securities, if any; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the net proceeds to us, if any. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Use of Proceeds </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as described in any applicable prospectus supplement or in any free writing prospectus we have authorized for use in connection with a specific offering, we intend to use the net proceeds from the sale of the securities under this prospectus for general corporate purposes, which may include funding research and development, capital expenditures, working capital and general and administrative expenses. See &#8220;<font style="font-style: italic;">Use of Proceeds</font>&#8221; on page <a href="#tUSE">10</a> of this prospectus.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Implications of being an Emerging Growth Company </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the JOBS Act. As an emerging growth company, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, as amended (the &#8220;Sarbanes-Oxley Act&#8221;), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 10-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20068427x1_s3_106-summary_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act are required to comply with the new or revised financial accounting standards. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our Class A Common Stock held by non-affiliates exceeds $700 million as of any June 30 before that time, in which case we would no longer be an emerging growth company as of the following December 31. References herein to &#8220;emerging growth company&#8221; have the meaning associated with it in the JOBS Act. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">New York Stock Exchange Listing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our Class&#160;A Common Stock trades on the NYSE under the ticker symbol &#8220;BRCC.&#8221; </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 11-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_107-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investing in our securities involves risks. Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed above under &#8220;Cautionary Note&#160;Regarding Forward-Looking Statements,&#8221; you should carefully consider the specific risks incorporated by reference in this Prospectus to our most recent Annual Report on Form&#160;10-K and any subsequent Quarterly Reports on Form&#160;10-Q or Current Reports on Form&#160;8-K, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information contained in any applicable prospectus supplement and any applicable free writing prospectus before acquiring any such securities. If any of these risks actually occur, it may materially harm our business, financial condition, liquidity and results of operations. As a result, the market price of our securities could decline, and you could lose all or part of your investment. Additionally, the risks and uncertainties incorporated by reference in this prospectus or any prospectus supplement are not the only risks and uncertainties that we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial, but that could later become material, may also adversely affect our business.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 12-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_108-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUSE"><!--Anchor--></a>USE OF PROCEEDS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as otherwise provided in a prospectus supplement in connection with an offering of securities pursuant to this prospectus or in any free writing prospectus we have authorized for use in connection with a specific offering, we currently intend to use the net proceeds from the sale of any securities under this prospectus primarily for general corporate purposes. General corporate purposes may include, without limitation, working capital, capital expenditures and repayment and refinancing of debt. We may also use a portion of the net proceeds to in-license, acquire, or invest in complementary companies or businesses, products, services, technologies or other assets. However, we do not have any agreements or commitments to enter into any material acquisitions or investments at this time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pending any specific application, we may initially invest the net proceeds in investment-grade, interest-bearing securities, U.S. federal government or agency-issued obligations, FDIC-insured certificates of deposit, municipal bonds and money market accounts or apply them to the reduction of short-term indebtedness until they are used for their stated purpose. The amounts of and timing of our use of the net proceeds from the sale of securities under this prospectus will depend on a number of factors. As of the date of this prospectus, we have not determined the amount of cannot specify with certainty all of the particular uses for the net proceeds. As a result, management will retain broad discretion over the allocation of net proceeds. We will set forth in the applicable prospectus supplement or free writing prospectus our intended use for the net proceeds, if any, received from the sale of any securities sold pursuant to such prospectus supplement or free writing prospectus. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 13-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOC"><!--Anchor--></a>DESCRIPTION OF CAPITAL STOCK </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following summary of the material terms of our capital stock is not intended to be a complete summary of the rights and preferences of such securities and is qualified in its entirety by the Company&#8217;s Amended and Restated Certificate of Incorporation (the &#8220;Charter&#8221;) and Amended and Restated By-Laws (the &#8220;Bylaws&#8221;). The full text of the Charter and Bylaws are filed as exhibits to the registration statement of which this prospectus is a part. For a complete description of the rights and preferences of our securities, we urge you to read the Charter and Bylaws and the applicable provisions of Delaware law. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Authorized and Outstanding Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Charter authorizes the issuance of 2,802,500,000 shares, consisting of four classes of stock as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">1,000,000 shares of undesignated preferred stock, par value $0.0001 per share; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">2,500,000,000 shares of Class&#160;A Common Stock, par value $0.0001 per share; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">300,000,000 shares of Class&#160;B Common Stock, par value $0.0001 per share (the &#8220;Class&#160;B Common Stock&#8221;); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">1,500,000 shares of Class&#160;C Common Stock, par value $0.0001 per share (the &#8220;Class&#160;C Common Stock&#8221;), divided into two series as follows: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">750,000 shares of Series&#160;C-1 Common Stock, par value $0.0001 per share; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">750,000 shares of Series&#160;C-2 Common Stock, par value $0.0001 per share. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of March 23, 2026, 116,470,011 shares of Class&#160;A Common Stock, 132,655,046 shares of Class&#160;B Common Stock and no shares of Class&#160;C Common Stock are issued and outstanding. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Common Stock</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Voting Power </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as otherwise provided in the Charter or as required by applicable law, holders of our Class&#160;A Common Stock and our Class&#160;B Common Stock are each entitled to one vote per share, and holders of our Class&#160;C Common Stock do not have any voting rights. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Dividends </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our Class&#160;A Common Stock are entitled to receive dividends and other distributions as may from time to time be declared by the Company&#8217;s board of directors (the &#8220;Board&#8221;) in its discretion out of legally available Company assets, ratably in proportion to the number of shares held by each such holder, and at such times and in such amounts as the Board in its discretion may determine. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No dividends or other distributions will be declared or paid on the Class&#160;B Common Stock or the Class&#160;C Common Stock. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Cancellation and Conversion of Class&#160;B Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event that any outstanding share of Class&#160;B Common Stock shall cease to be held directly or indirectly by a holder of a Common Unit, such share shall automatically and without further action on the part of the Company or any holder of Class&#160;B Common Stock be transferred to the Company and cancelled for no consideration. We shall not issue additional shares of Class&#160;B Common Stock after the Closing Date other than in connection with the valid issuance of Common Units or the conversion of any Restricted Common Units into Common Units upon the occurrence of an applicable Vesting Event. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Preemptive or Other Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the Second Amended and Restated Certificate of Incorporation, our stockholders have no preemptive or other subscription rights, and there are no sinking fund or redemption provisions applicable to our Common Stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 14-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Transfers of Class B Common Stock and Class&#160;C Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A holder of Class&#160;B Common Stock may transfer or assign shares of Class&#160;B Common only if such holder also simultaneously transfers an equal number of such holder&#8217;s Common Units in compliance with and as permitted by the LLC Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No share of Class&#160;C Common Stock may be transferred, other than to the holder of such share of Class&#160;C Common Stock&#8217;s permitted transferees under the LLC Agreement, prior to the Conversion Date of such shares of Class&#160;C Common Stock, at which time the shares of Class&#160;A Common Stock into which such shares of Class&#160;C Common Stock convert in accordance with the provisions of the Charter may be transferred, subject to any restrictions on transfer applicable to the holder of such Class&#160;A Common Stock and applicable law. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Liquidation, Dissolution or Winding Up</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, after payment of debts and other liabilities and of preferential and after the rights of holders of preferred stock, if any, have been satisfied, the holders of all outstanding shares of Class&#160;A Common Stock will be entitled to receive the remaining assets of the Company available for distribution ratably in proportion to the number of shares held by each such stockholder. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The holders of Class&#160;B Common Stock and Class&#160;C Common Stock are not entitled to receive any Company assets in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Election of Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the Investor Rights Agreement, directors of the Company shall be elected by a majority of the votes cast at an annual meeting of stockholders by holders of Class&#160;A Common Stock and Class&#160;B Common Stock, voting as a single class. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Public Benefit Corporation Status </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As a public benefit corporation, the Board is required by the Delaware General Corporation Law (&#8220;DGCL&#8221;) to manage or direct the Company&#8217;s business and affairs in a manner that balances the pecuniary interests of the Company&#8217;s stockholders, the best interests of those materially affected by our conduct, and the Company&#8217;s public benefit purpose. However, the Board does not have any duty to any person on account of any interest of such person in the Company&#8217;s public benefit purpose or on account of any interest materially affected by the Company&#8217;s conduct, and its balance requirement described in the previous sentence will be deemed satisfied if the Board&#8217;s decision is both informed and disinterested and not such that no person of ordinary sound judgment would approve. The Company is also required to assess its benefit performance internally and to disclose to stockholders at least biennially a report that details its promotion of the public benefits identified in the Charter and of the best interests of those materially affected by its conduct. It is expected that the Board will measure the Company&#8217;s benefit performance against the objectives and standards proposed by it and approved by the Board. When determining the objectives and standards by which the Board will measure its public benefit performance, the Board will consider, among other factors, whether the objectives and standards are (i) comprehensive in that they assess the positive impact of the Company&#8217;s business on the communities in which it operates, and society, taken as a whole, (ii) credible in that they are comparable to the objectives and standards created by independent third parties that evaluate the corporate ethics, sustainability and governance practices of other public benefit corporations, and (iii)transparent in that the criteria considered for measuring such objectives and standards be made publicly available, including disclosing the process by which revisions to the objectives and standards are made and whether such objectives and standards present real or potential conflicts of interests. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the DGCL, the Company&#8217;s stockholders may bring a derivative suit to enforce this requirement only if they own (individually or collectively), at least 2% of the Company&#8217;s outstanding shares or, upon the Company&#8217;s listing, the lesser of such percentage or shares of at least $2&#160;million in market value. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Anti-Takeover Effects of the Charter, the Bylaws and Certain Provisions of Delaware Law </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Charter, the Bylaws and the DGCL contain provisions, which are summarized in the following paragraphs, which are intended to enhance the likelihood of continuity and stability in the composition of the Board and to discourage certain types of transactions that may involve an actual or threatened acquisition of the Company. These provisions are intended to avoid costly takeover battles, reduce the Company&#8217;s vulnerability to a hostile change of </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 15-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">control or other unsolicited acquisition proposal, and enhance the ability of the Board to maximize stockholder value in connection with any unsolicited offer to acquire the Company. However, these provisions may have the effect of delaying, deterring or preventing a merger or acquisition of the Company by means of a tender offer, a proxy contest or other takeover attempt that a stockholder might consider in its best interest, including attempts that might result in a premium over the prevailing market price for the shares of Class&#160;A Common Stock. The Charter provides that any action required or permitted to be taken by the Company&#8217;s stockholders must be effected at a duly called annual or special stockholder meeting of such stockholders and may not be effected by any consent in writing by such holders unless such action is recommended or approved by all directors of the Board then in office, except that holders of Class&#160;B Common Stock or one or more series of Preferred Stock, if such series are expressly permitted to do so by the certificate of designation relating to such series, may take any action by written consent if such action permitted to be taken by such holders and the written consent is signed by the holders of outstanding shares of the relevant class or series having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Authorized but Unissued Capital Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of the NYSE, which would apply if and so long as the Class&#160;A Common Stock remains listed on the NYSE, require stockholder approval of certain issuances equal to or exceeding 20% of then outstanding voting power or then outstanding number of shares of Class&#160;A Common Stock. Additional shares that may be issued in the future may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless required by law or by any stock exchange on which our Class&#160;A Common Stock may be listed, the authorized shares of preferred stock will be available for issuance without further action by our stockholders. Our Charter authorizes the Board to issue up to 1,000,000 shares of preferred stock in one or more series and to establish, from time to time, the number of shares to be included in each series of preferred stock, and to fix the designation, powers, privileges, preferences, and relative participating, optional or other rights, if any, of the shares of each series of preferred stock, and any of its qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Our Board is also able to increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series of preferred stock then outstanding, without any further vote or action by the stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">One of the effects of the existence of unissued and unreserved common stock or preferred stock may be to enable the Board to issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise and thereby protect the continuity of management and possibly deprive stockholders of opportunities to sell their shares of Class&#160;A Common Stock at prices higher than prevailing market prices. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Election of Directors and Vacancies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Charter provides that the Board will determine the number of directors who will serve on the board, subject to the rights set forth in the Investor Rights Agreement. The Board is divided into three classes designated as Class&#160;I, Class&#160;II and Class&#160;III. At each annual meeting of stockholders, directors will be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting of the stockholders. There is no limit on the number of terms a director may serve on the Board. Subject to the Investor Rights Agreement, the term of all Class&#160;I directors shall automatically become one year commencing on the seventh annual meeting of stockholders following the consummation of the business combination contemplated by that certain Business Combination Agreement, dated as of November&#160;2, 2021, as amended (such transaction, the &#8220;Business Combination&#8221;), the term of all Class&#160;II directors shall automatically become one year commencing on the eighth annual meeting of stockholders following the consummation of the Business Combination and the term of all Class&#160;III directors shall automatically become one year commencing on the ninth annual meeting of stockholders following the consummation of the Business Combination, with all directors having a term of one year from and after such ninth annual meeting of stockholders following the consummation of the Business Combination. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the Charter provides that any vacancy on the Board, including a vacancy that results from an increase in the number of directors or a vacancy that results from the removal of a director with cause, may be filled only by a majority of the directors then in office, subject to the provisions of the Investor Rights Agreement and any rights of the holders of Preferred Stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 16-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding the foregoing provisions of this section, each director will serve until his successor is duly elected and qualified or until his earlier death, resignation, retirement, disqualification or removal. No decrease in the number of directors constituting the Board will shorten the term of any incumbent director. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Business Combinations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has elected not to be governed by Section&#160;203 of the DGCL. Notwithstanding the foregoing, the Charter provides that the Company will not engage in any &#8220;business combinations&#8221; (as defined in the Charter), at any point in time at which the Company&#8217;s Common Stock is registered under Section&#160;12(b) or 12(g) of the Exchange Act, with any &#8220;interested stockholder&#8221; (as defined in the Charter) for a three-year period after the time that such person became an interested stockholder unless: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">prior to such time, the Board approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the Company outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned by (i) persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at or subsequent to such time, the business combination is approved by the Board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 662&#8725;3% of the outstanding voting stock of the Company which is not owned by the interested stockholder. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the Charter, a &#8220;business combination&#8221; is defined to generally include a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation&#8217;s outstanding voting stock. The Charter expressly excludes Evan Hafer, certain of its transferees and its successors and affiliates from the definition of &#8220;interested stockholder&#8221; irrespective of the percentage ownership of the total voting power beneficially owned by them. Under certain circumstances, such provisions in the Charter make it more difficult for a person who would be an &#8220;interested stockholder&#8221; to effect various business combinations with a corporation for a three-year period. Accordingly, such provisions in the Charter could have an anti-takeover effect with respect to certain transactions which the Board does not approve in advance. Such provisions may encourage companies interested in acquiring the Company to negotiate in advance with the Board because the stockholder approval requirement would be avoided if the Board approves either the business combination or the transaction that results in the stockholder becoming an interested stockholder. However, such provisions also could discourage attempts that might result in a premium over the market price for the shares held by stockholders. These provisions also may make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Quorum </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Bylaws provide that at any meeting of the Board a majority of the total number of directors then in office constitutes a quorum for all purposes. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">No Cumulative Voting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under Delaware law, the right to vote cumulatively does not exist unless the Charter expressly authorizes cumulative voting. The Charter does not authorize cumulative voting. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">General Stockholder Meetings </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Charter provides that special meetings of stockholders may be called only by or at the direction of the Board, the Chairman of the Board or the Chief Executive Officer. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Requirements for Advance Notification for Stockholder Meetings, Nominations and Proposals </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the Board or a committee of the Board. For any matter to be &#8220;properly brought&#8221; before a meeting, a stockholder will have to comply with advance </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 17-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">notice requirements and provide the Company with certain information. Generally, to be timely, a stockholder&#8217;s notice must be received at the Company&#8217;s principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the immediately preceding annual meeting of stockholders (for the purposes of the first annual meeting of the stockholders of the Company following the adoption of the Bylaws, the date of the preceding annual meeting shall be deemed to be June&#160;1 of the preceding calendar year). The Bylaws also specify requirements as to the form and content of a stockholder&#8217;s notice. The Bylaws allow the presiding officer at a meeting of the stockholders to adopt rules and regulations for the conduct of meetings which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to influence or obtain control of the Company. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Supermajority Provisions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Charter and the Bylaws provide that the Board is expressly authorized to make, alter, amend, change, add to, rescind or repeal, in whole or in part, the Bylaws without a stockholder vote in any matter not inconsistent with the laws of the State of Delaware or the Charter. Any amendment, alteration, rescission or repeal of the Bylaws by the Company&#8217;s stockholders requires the affirmative vote of the holders of at least 662&#8725;3%, in case of provisions in Article&#160;I. Article&#160;II and Article&#160;IV of the Bylaws, and a majority, in case of any other provisions, in voting power of all then outstanding shares of the Company&#8217;s stock entitled to vote thereon, voting together as a single class. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DGCL provides generally that the affirmative vote of a majority of the outstanding shares entitled to vote thereon, voting together as a single class, is required to amend a corporation&#8217;s Charter, unless the Charter requires a greater percentage. The Charter provides that Article&#160;X therein, including the provisions therein regarding competition and corporate opportunities, may be amended, altered, repealed or rescinded only by the affirmative vote of the holders of at least 80% in voting power of all then outstanding shares of the Company&#8217;s stock entitled to vote thereon, voting together as a single class. The Charter provides that Article&#160;V, Article&#160;VI, Article&#160;VII, Article&#160;VIII, Article&#160;IX, Article&#160;XII and Article&#160;XIII therein, including the following provisions therein may be amended, altered, repealed or rescinded only by the affirmative vote of the holders of at least 662&#8725;3% in voting power of all then outstanding shares of the Company&#8217;s stock entitled to vote thereon, voting together as a single class: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the provision requiring a 662&#8725;3% supermajority vote, in case of provisions in Article&#160;I, Article&#160;II and Article&#160;IV of the Bylaws, and a majority vote, in case of any other provisions, for stockholders to amend the Bylaws; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions providing for a classified Board (the election and term of directors); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions regarding filling vacancies on the Board and newly created directorships; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions regarding resignation and removal of directors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions regarding calling special meetings of stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions regarding stockholder action by written consent; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions eliminating monetary damages for breaches of fiduciary duty by a director; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions regarding the election not to be governed by Section&#160;203 of the DGCL; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the provisions regarding the selection of forum (see &#8220;- <font style="font-style: italic;">Exclusive Forum</font>&#8221;); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the amendment provision requiring that the above provisions be amended only with an 662&#8725;3% supermajority vote. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These provisions may have the effect of deterring hostile takeovers or delaying or preventing changes in control of the Company or its management, such as a merger, reorganization or tender offer. These provisions are intended to enhance the likelihood of continued stability in the composition of the Board and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of the Company. These provisions are designed to reduce the Company&#8217;s vulnerability to an unsolicited acquisition proposal. The provisions are also intended to discourage certain tactics that may be used in proxy fights. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">However, such provisions could have the effect of discouraging others from making tender offers for the Company&#8217;s shares and, as a consequence, may inhibit fluctuations in the market price of the Company&#8217;s shares that could result from actual or rumored takeover attempts. Such provisions may also have the effect of preventing changes in management. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 18-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Exclusive Forum </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Charter provides that, unless the Company consents in writing to the selection of an alternative forum, (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, other employee, agent or stockholder of the Company to the Company or the Company&#8217;s stockholders, or any claim for aiding and abetting such alleged breach, (iii) any action asserting a claim against the Company or any current or former director, officer, other employee, agent or stockholder of the Company (a) arising pursuant to any provision of the DGCL, the Charter (as it may be amended or restated) or the Bylaws or (b) as to which the DGCL confers jurisdiction on the Delaware Court of Chancery or (iv) any action asserting a claim against the Company or any current or former director, officer, other employee, agent or stockholder of the Company governed by the internal affairs doctrine of the law of the State of Delaware shall, as to any action in the foregoing clauses (i) through (iv), to the fullest extent permitted by law. be solely and exclusively brought in the Delaware Court of Chancery; provided, however, that the foregoing shall not apply to any claim (a) as to which the Delaware Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Delaware Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (b) which is vested in the exclusive jurisdiction of a court or forum other than the Delaware Court of Chancery, or (c) arising under federal securities laws, including the Securities Act, as to which the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum. Notwithstanding the foregoing, the provisions of Article&#160;XII of the Charter does not apply to suits brought to enforce any liability or duty created by the Exchange Act, or any other claim for which the federal district courts of the United States of America shall be the sole and exclusive forum. While Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder, Section&#160;27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Any person or entity purchasing or otherwise acquiring any interest in any shares of the Company&#8217;s capital stock shall be deemed to have notice of and to have consented to the forum provisions in the Charter. If any action the subject matter of which is within the scope of the forum provisions is filed in a court other than a court located within the State of Delaware (a &#8220;foreign action&#8221;) in the name of any stockholder, such stockholder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce the forum provisions (an &#8220;enforcement action&#8221;); and (y) having service of process made upon such stockholder in any such enforcement action by service upon such stockholder&#8217;s counsel in the foreign action as agent for such stockholder. This choice-of-forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with the Company or its directors, officers, stockholders, agents or other employees, which may discourage such lawsuits. We note that there is uncertainty as to whether a court would enforce this provision, and the enforceability of similar choice of forum provisions in other companies&#8217; charter documents has been challenged in legal proceedings. Further, investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. It is possible that a court could find these types of provisions to be inapplicable or unenforceable, and if a court were to find this provision of the Charter inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, the Company may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect the Company&#8217;s business, financial condition and results of operations and result in a diversion of the time and resources of the Company&#8217;s management and board of directors. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Conflicts of Interest </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Delaware law permits corporations to adopt provisions renouncing any interest or expectancy in certain opportunities that are presented to the corporation or its officers, directors or stockholders. The Charter, to the maximum extent permitted from time to time by Delaware law, renounces any interest or expectancy that the Company has in, or right to be offered an opportunity to participate in, specified business opportunities that are from time to time presented to the Company&#8217;s officers, directors or stockholders or their respective affiliates, other than those officers, directors, stockholders or affiliates who are employees of the Company or its subsidiaries. The Charter provides that, to the fullest extent permitted by law, none of the non-employee directors or his or her affiliates will have any duty to refrain from (i)&#160;engaging in a corporate opportunity in the same or similar lines of business in which the Company or its affiliates now engage or propose to engage or (ii) otherwise competing with the Company or its affiliates. In addition, to the fullest extent permitted by law, in the event that any non-employee director or any of his or her affiliates acquires knowledge of a potential transaction or other business opportunity which may be a corporate opportunity for itself or himself or herself or its or his or her affiliates or for the Company or its affiliates, such person will have no duty to </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 19-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">communicate or offer such transaction or business opportunity to the Company or any of its affiliates and they may take any such opportunity for themselves or offer it to another person or entity. The Charter does not renounce the Company&#8217;s interest in any business opportunity that is expressly offered to, or acquired or developed by a non-employee director solely in his or her capacity as a director or officer of the Company. To the fullest extent permitted by law, a corporate opportunity shall not be deemed to be a potential corporate opportunity for the Company if it is a business opportunity that (i) the Company is neither financially or legally able, nor contractually permitted to undertake, (ii) from its nature, is not in the line of the Company&#8217;s business or is of no practical advantage to the Company, (iii) is one in which the Company has no interest or reasonable expectancy, or (iv) is one presented to any account for the benefit of a member of the Board or such member&#8217;s affiliate over which such member of the Board has no direct or indirect influence or control, including, but not limited to, a blind trust. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Limitations on Liability and Indemnification of Officers and Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary duties, subject to certain exceptions. The Charter includes a provision that eliminates, to the fullest extent permitted by law, the personal liability of directors for monetary damages for any breach of fiduciary duty as a director. The effect of these provisions is to eliminate the rights of the Company and its stockholders, through stockholders&#8217; derivative suits on the Company&#8217;s behalf, to recover monetary damages from a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior. However, exculpation does not apply to any director if the director has acted in bad faith, knowingly or intentionally violated the law, authorized illegal dividends or redemptions or derived an improper benefit from his or her actions as a director. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Bylaws provide that the Company must indemnify and advance expenses to directors and officers to the fullest extent permitted by Delaware law. The Company is also expressly authorized to carry directors&#8217; and officers&#8217; liability insurance providing indemnification for directors, officers and certain employees for some liabilities. The Company believes that these indemnification and advancement provisions and insurance are useful to attract and retain qualified directors and executive officers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The limitation of liability, indemnification and advancement provisions in the Charter and the Bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit the Company and its stockholders. In addition, your investment may be adversely affected to the extent the Company pays the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. The Company believes that these provisions, liability insurance and the indemnity agreements are necessary to attract and retain talented and experienced directors and officers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to the Company&#8217;s directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise the Company has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Registration Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the closing of the Business Combination, the Company entered into the Investor Rights Agreement, pursuant to which, among other things, the Sponsor, Engaged Capital and certain of its affiliates, the BRCC Founder, the Engaged Equityholders (as such capitalized terms are defined therein) and certain other stockholders party thereto have specified rights to require the Company to register all or a portion of their shares under the Securities Act. The defined term Registrable Securities therein includes the shares of Class&#160;A Common Stock and warrants to purchase shares of Class&#160;A Common Stock (all of which were subsequently redeemed) issued in connection with the Business Combination. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Listing of Securities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our Class&#160;A Common Stock is listed on NYSE under the symbol &#8220;BRCC.&#8221; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 20-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOW"><!--Anchor--></a>DESCRIPTION OF WARRANTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue warrants to purchase shares of our Class&#160;A Common Stock and/or preferred stock in one or more series together with other securities or separately, as described in each applicable prospectus supplement. Below is a description of certain general terms and provisions of the warrants that we may offer. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, the form of warrant agreement, if any, including a form of warrant certificate, that describes the terms of the particular series of warrants we are offering. The following summaries of material provisions of the warrants and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to the particular series of warrants that we may offer under this prospectus. We urge you to read the applicable prospectus supplements related to the particular series of warrants that we may offer under this prospectus, as well as any related free writing prospectuses we have authorized for use in connection with a specific offering, and the complete warrant agreements and warrant certificates that contain the terms of the warrants. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">General Matters </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To the extent appropriate, the applicable prospectus supplement will contain, where applicable, the following terms of and other information relating to the warrants: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the specific designation and aggregate number of, and the price at which we will issue, the warrants; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the currency or currency units in which the offering price, if any, and the exercise price are payable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the designation, amount and terms of the securities purchasable upon exercise of the warrants; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if applicable, the exercise price for shares of our Class&#160;A Common Stock and the number of shares of Class&#160;A Common Stock to be received upon exercise of the warrants; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if applicable, the exercise price for shares of our preferred stock, the number of shares of preferred stock to be received upon exercise, and a description of that class or series of our preferred stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the date on which the right to exercise the warrants will begin and the date on which that right will expire or, if the warrants may not be continuously exercised throughout that period, the specific date or dates on which the warrants may be exercised; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">whether the warrants will be issued in fully registered form or bearer form, in definitive or global form or in any combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any applicable material U.S. federal income tax consequences; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if applicable, the date from and after which the warrants and the Class&#160;A Common Stock and/or, preferred stock will be separately transferable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">information with respect to book-entry procedures, if any; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any redemption or call provisions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether the warrants are to be sold separately or with other securities as parts of units; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any additional terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">18<br></div></div></div>
<!--End Page 21-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless otherwise provided in the applicable prospectus supplement, holders of equity warrants will not be entitled, by virtue of being such holders, to vote, consent, receive dividends, receive notice as stockholders with respect to any meeting of stockholders for the election of our directors or any other matter, or to exercise any rights whatsoever as stockholders. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Exercise of Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We will set forth on the reverse side of the warrant certificate and in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent in connection with the exercise of the warrant. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon receipt of the required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Governing Law </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless we provide otherwise in the applicable prospectus supplement, the warrants and any warrant agreements will be governed by and construed in accordance with the internal laws of the State of New York. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Enforceability of Rights by Holders of Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each warrant agent, if any, will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise of, its warrants. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">19<br></div></div></div>
<!--End Page 22-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOS"><!--Anchor--></a>DESCRIPTION OF SUBSCRIPTION RIGHTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue subscription rights to purchase Class&#160;A Common Stock, preferred stock, other securities described in this prospectus or any combination thereof. These subscription rights may be issued independently or together with any other security offered by us and may or may not be transferable by the securityholder receiving the subscription rights in such offering. In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more purchasers, including underwriters, pursuant to which such purchasers may be required to purchase any securities remaining unsubscribed for after such offering. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To the extent appropriate, the applicable prospectus supplement will contain, where applicable, the following terms of and other information relating to the subscription rights to purchase shares of our securities offered thereby: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the title of the subscription rights; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the date of determining the securityholders entitled to the subscription rights distribution; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the price, if any, for the subscription rights; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the exercise price payable for the Class A Common Stock, preferred stock or other securities upon the exercise of the subscription rights; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of subscription rights issued to each securityholder; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the amount of Class&#160;A Common Stock, preferred stock or other securities that may be purchased per each subscription right; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any provisions for adjustment of the amount of securities receivable upon exercise of the subscription rights or of the exercise price of the subscription rights; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the extent to which the subscription rights are transferable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the date on which the right to exercise the subscription rights shall commence, and the date on which the subscription rights shall expire; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the extent to which the subscription rights may include an over-subscription privilege with respect to unsubscribed securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the material terms of any standby underwriting or purchase arrangement entered into by us in connection with the offering of subscription rights; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any applicable federal income tax considerations; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any other terms of the subscription rights, including the terms, procedures and limitations relating to the transferability, exchange and exercise of the subscription rights. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Exercise of Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each subscription right will entitle the holder of subscription rights to purchase for cash the shares of Class&#160;A Common Stock, preferred stock, warrants, units or other securities, as applicable, at the exercise price provided in the applicable prospectus supplement. Subscription rights may be exercised at any time up to the close of business on the expiration date for the subscription rights provided in the applicable prospectus supplement. After the close of business on the expiration date, all unexercised subscription rights will be void. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders may exercise subscription rights as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly executed at the corporate trust office of the subscription rights or subscription agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the shares of Class&#160;A Common Stock, preferred stock, warrants, units or other securities, as applicable, purchasable upon exercise of the rights. If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters, brokers or dealers or through a combination of such methods, including pursuant to standby underwriting arrangements, as described in the applicable prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The rights agent for any rights we offer will be set forth in the applicable prospectus supplement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">20<br></div></div></div>
<!--End Page 23-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_109-description_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOU"><!--Anchor--></a>DESCRIPTION OF UNITS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue units consisting of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each series of units by unit certificates that we will issue under a separate agreement. We may issue units directly or under a unit agreement to be entered into between us and a unit agent. We will name any unit agent in the applicable prospectus supplement. Any unit agent will act solely as our agent in connection with the units of a particular series and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of units. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time, or at any time before a specified date. We may issue units in such amounts and in such numerous distinct series as we determine. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following description, together with the additional information included in the applicable prospectus supplement, summarizes the general features of the units that we may offer under this prospectus. You should read any prospectus supplement and any free writing prospectus we authorize for use in connection with a specific offering of units, as well as the complete unit agreements that contain the terms of the units. Specific unit agreements will contain additional important terms and provisions and we will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from another report that we file with the SEC, the form of each unit agreement relating to units offered under this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To the extent appropriate, the applicable prospectus supplement will contain, where applicable, the following terms and other information relating to the units: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the title of the series of units; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identification and description of the separate constituent securities comprising the units; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the price or prices at which the units will be issued; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the date, if any, on and after which the constituent securities comprising the units will be separately transferable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a discussion of certain United States federal income tax considerations applicable to the units; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other terms of the units and their constituent securities. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Issuance in Series </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may issue units in such amounts and in such numerous distinct series as we determine. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Enforceability of Rights by Holders of Units </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder of any unit. A single bank or trust company may act as unit agent for more than one series of units. A unit agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a unit may, without the consent of the related unit agent or the holder of any other unit, enforce by appropriate legal action its rights as holder under any security included in the unit. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We, the unit agents and any of their agents may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate for any purpose and as the person entitled to exercise the rights attaching to the units so requested, despite any notice to the contrary. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">21<br></div></div></div>
<!--End Page 24-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_110-plan_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPOD"><!--Anchor--></a>PLAN OF DISTRIBUTION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may sell the securities offered hereby directly to one or more purchasers, through agents, or through underwriters or dealers designated from time to time. The distribution of securities may be effected from time to time in one or more transactions at a fixed price or prices (which may be changed from time to time), at market prices prevailing at the times of sale, at prices related to these prevailing market prices or at negotiated prices. To the extent required, an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement of which this prospectus is part, will be prepared and will set forth the following information: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the terms of the securities to which such prospectus supplement relates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the name or names of any underwriters, if any; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the purchase price of the securities and the proceeds we will receive from the sale; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any underwriting discounts and other items constituting underwriters&#8217; compensation; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any discounts or concessions allowed or reallowed or paid to dealers. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Underwriters named in the prospectus supplement, if any, are only underwriters of the securities offered with such prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the limitations set forth in any applicable registration rights agreement, we may use any one or more of the following methods when selling the securities offered by this prospectus: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ordinary brokerage transactions and transactions in which the broker solicits purchasers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">block trades in which the broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an over-the-counter distribution in accordance with the rules of NYSE; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">through trading plans entered pursuant to Rule&#160;10b5-1 under the Exchange Act that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">through one or more underwritten offerings on a firm commitment or best efforts basis; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">settlement of short sales entered into after the date of this prospectus; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">agreements with broker-dealers to sell a specified number of the securities at a stipulated price per share; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">in &#8220;at the market&#8221; offerings, as defined in Rule&#160;415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">directly to purchasers, including through a specific bidding, auction or other process or in privately negotiated transactions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">through a combination of any of the above methods of sale; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other method permitted pursuant to applicable law. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There can be no assurance that we will sell all or any of the securities offered by this prospectus. We have the sole and absolute discretion not to accept any purchase offer or make any sale of securities if we deem the purchase price to be unsatisfactory at any particular time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with distributions of the securities or otherwise, we may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of the securities in the course of hedging the positions they assume with us. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to facilitate the offering of the securities, any underwriters or agents, as the case may be, involved in the offering of such securities may engage in transactions that stabilize, maintain or otherwise affect the price of our </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">22<br></div></div></div>
<!--End Page 25-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_110-plan_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">securities. Specifically, the underwriters or agents, as the case may be, may overallot in connection with the offering, creating a short position in our securities for their own account. In addition, to cover overallotments or to stabilize the price of our securities, the underwriters or agents, as the case may be, may bid for, and purchase, such securities in the open market. Finally, in any offering of securities through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allotted to an underwriter or a broker-dealer for distributing such securities in the offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. The underwriters or agents, as the case may be, are not required to engage in these activities, and may end any of these activities at any time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may solicit offers to purchase the securities directly from, and may sell such securities directly to, institutional investors or others. In this case, no underwriters or agents would be involved. The terms of any of those sales, including the terms of any bidding or auction process, if utilized, will be described in the applicable prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">It is possible that one or more underwriters may make a market in our securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We cannot give any assurance as to the liquidity of the trading market for our securities. Our shares of Class&#160;A Common Stock are currently listed on NYSE under the symbol &#8220;BRCC.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may authorize underwriters, broker-dealers or agents to solicit offers by certain purchasers to purchase the securities at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any commissions we pay for solicitation of these contracts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In effecting sales, broker-dealers or agents engaged by us may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from us in amounts to be negotiated immediately prior to the sale. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In compliance with the guidelines of the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;), the aggregate maximum discount, commission, fees or other items constituting underwriting compensation to be received by any FINRA member or independent broker-dealer will not exceed 8% of the gross proceeds of any offering pursuant to this prospectus and any applicable prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If at the time of any offering made under this prospectus a member of FINRA participating in the offering has a &#8220;conflict of interest&#8221; as defined in FINRA Rule&#160;5121 (&#8220;Rule&#160;5121&#8221;), that offering will be conducted in accordance with the relevant provisions of Rule&#160;5121. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Underwriters, broker-dealers or agents may facilitate the marketing of an offering online directly or through one of their affiliates. In those cases, prospective investors may view offering terms and a prospectus online and, depending upon the particular underwriter, broker-dealer or agent, place orders online or through their financial advisors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The underwriters, broker-dealers and agents may engage in transactions with us and may have banking, lending or other relationships with us or perform services for us in the ordinary course of business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to comply with the securities laws of certain states, if applicable, the securities must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We and any other persons participating in the sale or distribution of the securities will be subject to applicable provisions of the Securities Act and the Exchange Act, and the rules and regulations thereunder, including, without limitation, Regulation M. These provisions may restrict certain activities of, and limit the timing of purchases and sales of any of the securities by, us or any other person, which limitations may affect the marketability of the shares of the securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may indemnify any agent, broker-dealer or underwriter that participates in transactions involving the sale of the securities against certain liabilities, including liabilities arising under the Securities Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Agents, broker-dealers and underwriters may be entitled to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which the agents, broker-dealers or underwriters may be required to make in respect thereof. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">23<br></div></div></div>
<!--End Page 26-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_111-tax_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tMUS"><!--Anchor--></a>MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of certain United States federal income tax consequences of the ownership and disposition of Class&#160;A Common Stock as of the date hereof. This summary is limited to beneficial owners who will hold the Class&#160;A Common Stock as &#8220;capital assets&#8221; within the meaning of Section&#160;1221 of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A &#8220;U.S. holder&#8221; means a beneficial owner of the Class&#160;A Common Stock (other than an entity or arrangement treated as a partnership for United States federal income tax purposes) that is , for United States federal income tax purposes, any of the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an individual who is a citizen or resident of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a corporation (or any other entity treated as a corporation for United States federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">an estate the income of which is subject to United States federal income taxation regardless of its source; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a trust if it (1) is subject to the primary supervision of a court within the United States and one or more United&#160;States persons have the authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A &#8220;non-U.S. holder&#8221; means a beneficial owner of the Class&#160;A Common Stock that is neither a U.S. holder nor a partnership for U.S. federal income tax purposes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary is based upon provisions of the Code, and regulations, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), in each case as in effect as of the date hereof. Those authorities are subject to different interpretations and may be changed, perhaps retroactively, so as to result in United States federal income tax consequences different from those summarized below. This summary does not address all aspects of United States federal income taxes and does not deal with the effects of other U.S. federal tax laws, such as estate and gift tax laws, the alternative minimum tax, the Medicare contribution tax on net investment income, or rules regarding qualified small business stock, and does not deal with state, local, non-U.S. or other tax considerations that may be relevant to U.S. and non-U.S. holders in light of their particular circumstances. In addition, it does not represent a detailed description of the United States federal income tax consequences applicable to you if you are subject to special treatment under the United States federal income tax laws, such as: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">insurance companies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-exempt or governmental organizations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">financial institutions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">brokers or dealers in securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;regulated investment companies&#8221; and &#8220;real estate investment trusts&#8221;; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">pension plans; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;qualified foreign pension funds,&#8221; or entities wholly owned by a &#8220;qualified foreign pension fund&#8221;; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and partners and investors therein); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons deemed to sell our common stock under the constructive sale provisions of the Code; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">persons that hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or other integrated investment; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">U.S. expatriates. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We cannot assure you that a change in law will not significantly alter the tax considerations that we describe in this summary or that the IRS or a court will not take a contrary position to that discussed below. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">24<br></div></div></div>
<!--End Page 27-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_111-tax_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a partnership (or other entity treated as a partnership for United States federal income tax purposes) holds Class&#160;A Common Stock, the tax treatment of a partner will generally depend upon the status of the partner, the activities of the partnership and certain determinations made at the partner level. If you are a partner of a partnership holding Class&#160;A Common Stock, you are urged to consult your tax advisors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each prospective Investor is urged to consult its own tax advisors concerning the particular United States federal income tax consequences related to the purchase, ownership and disposition of Class&#160;A Common Stock, as well as the consequences arising under other United States federal tax laws and the laws of any other taxing jurisdiction.<font style="font-weight: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Tax Considerations Applicable to U.S. Holders </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Distributions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event that we make a distribution of cash or other property (other than certain pro rata distributions of our stock) in respect of our Class&#160;A Common Stock, the distribution generally will be treated as a dividend for United States federal income tax purposes to the extent it is paid from our current or accumulated earnings and profits, as determined under United States federal income tax principles. Any portion of a distribution that exceeds our current and accumulated earnings and profits generally will be treated first as a tax-free return of capital, causing a reduction in the adjusted tax basis of a U.S. holder&#8217;s Class&#160;A Common Stock, and to the extent the amount of the distribution exceeds a U.S. holder&#8217;s adjusted tax basis in our Class&#160;A Common Stock, the excess will be treated as gain from the disposition of our Class&#160;A Common Stock (the tax treatment of which is discussed below under &#8220;-<font style="font-style: italic;">Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock</font>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dividends we pay to a U.S. holder that is a taxable corporation will generally qualify for the dividends received deduction if the requisite holding period is satisfied. With certain exceptions (including dividends treated as investment income for purposes of investment interest deduction limitations), and provided certain holding period requirements are met, dividends we pay to a non-corporate U.S. holder will generally constitute &#8220;qualified dividends&#8221; that will be subject to tax at the preferential tax rate accorded to long-term capital gains. Non-corporate U.S. holders that do not meet a minimum holding period requirement or that elect to treat the dividend income as &#8220;investment income&#8221; pursuant to Section&#160;163(d)(4) of the Code (dealing with the deduction for investment interest expense) will not be eligible for the reduced rates of taxation applicable to qualified dividends. In addition, the rate reduction will not apply to dividends if the recipient of a dividend is obligated to make related payments with respect to positions in substantially similar or related property. This disallowance applies even if the minimum holding period has been met. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the applicable holding period requirements are not satisfied, a corporation may not be able to qualify for the dividends received deduction and would have taxable income equal to the entire dividend amount, and non-corporate holders may be subject to tax on such dividend at ordinary income tax rates instead of the preferential rates that apply to qualified dividend income. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Class&#160;A Common Stock</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A U.S. holder generally will recognize gain or loss on the sale, taxable exchange or other taxable disposition of our Class&#160;A Common Stock, including on a redemption that is treated as a sale or exchange under Section&#160;302 of the Code. In the case of a redemption, such redemption generally will be treated as a sale or exchange of the Class&#160;A Common Stock (rather than as a corporate distribution) if the redemption (i) is &#8220;substantially disproportionate&#8221; with respect to the U.S. holder, (ii) results in a &#8220;complete termination&#8221; of the U.S. holder&#8217;s interest or (iii) is &#8220;not essentially equivalent to a dividend&#8221; with respect to the U.S. holder. The redemption of our Class&#160;A Common Stock will not be &#8220;essentially equivalent to a dividend&#8221; if a U.S. holder&#8217;s redemption results in a &#8220;meaningful reduction&#8221; of the U.S. holder&#8217;s proportionate interest in us. Whether the redemption will result in a meaningful reduction in a U.S. holder&#8217;s proportionate interest will depend on the particular facts and circumstances. However, the IRS has indicated in a published ruling that even a small reduction in the proportionate interest of a small minority stockholder in a publicly held corporation who exercises no control over corporate affairs may constitute such a &#8220;meaningful reduction.&#8221; A U.S.&#160;holder should consult with its own tax advisors as to the tax consequences of a redemption. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any such gain or loss recognized on the sale, taxable exchange or other taxable disposition of our Class&#160;A Common Stock, including on a redemption as described above, will be capital gain or loss, and will be long-term capital gain or loss if the U.S. holder&#8217;s holding period for the Class&#160;A Common Stock so disposed of exceeds one year. The amount of gain or loss recognized will generally be equal to the difference between (1) the sum of the amount of cash and the fair </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">25<br></div></div></div>
<!--End Page 28-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_111-tax_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">market value of any property received in such disposition and (2) the U.S. holder&#8217;s adjusted tax basis in its Class&#160;A Common Stock so disposed of. A U.S. holder&#8217;s adjusted tax basis in its Class&#160;A Common Stock will generally equal the U.S. holder&#8217;s acquisition cost for such Class&#160;A Common Stock, less any prior distributions treated as a return of capital. The deductibility of capital losses is subject to limitations. Long-term capital gains recognized by non-corporate U.S.&#160;holders are generally eligible for reduced rates of tax. If the U.S. holder&#8217;s holding period for the Class&#160;A Common Stock so disposed of is one year or less, any gain on a sale or other taxable disposition of the shares would be subject to short-term capital gain treatment and would be taxed at ordinary income tax rates. The deductibility of capital losses is subject to limitations. Any gain or loss recognized by a U.S. holder on the sale or exchange of our Class&#160;A Common Stock will generally be treated as U.S. source gain or loss. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Tax Considerations Applicable to Non-U.S. Holders </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Distributions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event that we make a distribution of cash or other property (other than certain pro rata distributions of our stock) in respect of Class&#160;A Common Stock, the distribution generally will be treated as a dividend for United States federal income tax purposes to the extent it is paid from our current or accumulated earnings and profits, as determined under United States federal income tax principles. Any portion of a distribution that exceeds our current and accumulated earnings and profits generally will be treated first as a tax-free return of capital, causing a reduction in the adjusted tax basis of a non-U.S. holder&#8217;s Class&#160;A Common Stock (but not below zero), and to the extent the amount of the distribution exceeds a non-U.S. holder&#8217;s adjusted tax basis in Class&#160;A Common Stock, the excess will be treated as gain from the disposition of Class&#160;A Common Stock (the tax treatment of which is discussed below under &#8220;- <font style="font-style: italic;">Disposition of Class&#160;A Common Stock</font>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dividends paid to a non-U.S. holder generally will be subject to withholding of United States federal income tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">However, dividends that are effectively connected with the conduct of a trade or business by the non-U.S. holder within the United States (and, if required by an applicable income tax treaty, are attributable to a United States permanent establishment) are not subject to the withholding tax, provided certain certification and disclosure requirements are satisfied. Instead, such dividends are subject to United States federal income tax on a net income basis generally in the same manner as if the non-U.S. holder were a United States person as defined under the Code. Any such effectively connected dividends received by a foreign corporation may be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A non-U.S. holder who wishes to claim the benefit of an applicable treaty rate and avoid backup withholding, as discussed below, for dividends generally will be required (a) to provide the applicable withholding agent with a properly executed IRS Form&#160;W-BEN or Form&#160;W-8BEN-E (or other applicable form) certifying under penalty of perjury that such holder is not a United States person as defined under the Code and is eligible for treaty benefits or (b) if Class&#160;A Common Stock is held through certain foreign intermediaries, to satisfy the relevant certification requirements of applicable United States Treasury regulations. Special certification and other requirements apply to certain non-U.S. holders that are pass-through entities rather than corporations or individuals. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A non-U.S. holder eligible for a reduced rate of United States federal withholding tax pursuant to an income tax treaty may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Disposition of Class&#160;A Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the discussion of backup withholding and FATCA below, any gain realized by a non-U.S. holder on the sale or other disposition of Class&#160;A Common Stock generally will not be subject to United States federal income tax unless: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the gain is effectively connected with a trade or business of the non-U.S. holder in the United States (and, if required by an applicable income tax treaty, is attributable to a United States permanent establishment of the non-U.S. holder); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are or have been a &#8220;United States real property holding corporation&#8221; for United States federal income tax purposes at any time during the shorter of the five-year period ending on the date of the sale or other </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">26<br></div></div></div>
<!--End Page 29-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_111-tax_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">disposition or the period that the non-U.S. holder held the Class&#160;A Common Stock and, in the case where Class&#160;A Common Stock is considered regularly traded on an established securities market for this purpose, the non-U.S. holder has owned, directly or constructively, more than 5% of the Class&#160;A Common Stock at any time within such period. There can be no assurance that Class&#160;A Common Stock will be treated as regularly traded on an established securities market for this purpose. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A non-U.S. holder described in the first bullet point immediately above generally will be subject to tax on the gain derived from the sale or other disposition in the same manner as if the non-U.S. holder were a U.S. holder. In addition, if any non-U.S. holder described in the first bullet point immediately above is a foreign corporation, the gain realized by such non-U.S. holder may be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty. An individual non-U.S. holder described in the second bullet point immediately above generally will be subject to a 30% (or such lower rate as may be specified by an applicable income tax treaty) tax on the gain derived from the sale or other disposition, which gain may be offset by certain United States source capital losses even though the individual is not considered a resident of the United States, <font style="font-style: italic;">provided</font> that the non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses. Non-U.S. holders are urged to consult their tax advisors regarding possible eligibility for benefits under income tax treaties. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Generally, a corporation is a &#8220;United States real property holding corporation&#8221; if the fair market value of its United&#160;States real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests and its other assets used or held for use in a trade or business (all as determined for United States federal income tax purposes). Although there can be no assurance, we believe we are not and do not anticipate becoming a &#8220;United States real property holding corporation&#8221; for United States federal income tax purposes. If the third bullet point above applies to a non-U.S. holder and applicable exceptions are not available, gain recognized by such holder on the sale, exchange or other disposition of our Class&#160;A Common Stock will be subject to tax at generally applicable U.S.&#160;federal income tax rates. In addition, a buyer of our Class&#160;A Common Stock from such holder may (to the extent the publicly traded exemption to such withholding does not apply) be required to withhold U.S. income tax at a rate of 15%&#160;of the amount realized upon such disposition. Non-U.S. holders are urged to consult their tax advisors regarding the application of these rules. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Additional Withholding Requirements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under Sections 1471 through 1474 of the Code (such Sections commonly referred to as &#8220;FATCA&#8221;), a 30%&#160;United&#160;States federal withholding tax may apply to any dividends on, or gross proceeds from the sale or other disposition of, Class&#160;A Common Stock paid to (i) a &#8220;foreign financial institution&#8221; (as specifically defined in the Code and whether such foreign financial institution is the beneficial owner or an intermediary) which does not provide sufficient documentation, typically on IRS Form&#160;W-8BEN-E, evidencing either (x) an exemption from FATCA, or (y)&#160;its compliance (or deemed compliance) with FATCA (which may alternatively be in the form of compliance with an intergovernmental agreement with the United States) in a manner which avoids withholding, or (ii) a &#8220;non-financial foreign entity&#8221; (as specifically defined in the Code and whether such non-financial foreign entity is the beneficial owner or an intermediary) which does not provide sufficient documentation, typically on IRS Form&#160;W-8BEN-E, evidencing either (x) an exemption from FATCA, or (y) adequate information regarding certain substantial United States beneficial owners of such entity (if any). Documentation that holders provide in order to be treated as FATCA compliant may be reported to the IRS and other tax authorities, including information about a holder&#8217;s identity, its FATCA status, and if applicable, certain of its direct and indirect U.S. owners. If a dividend payment is both subject to withholding under FATCA and subject to the withholding tax discussed above under &#8220;<font style="font-style: italic;">Tax Considerations Applicable to Non-U.S. Holders - Distributions</font>,&#8221; the withholding under FATCA may, under certain circumstances, be credited against, and therefore reduce, such other withholding tax. An intergovernmental agreement between the United States and a non-U.S.&#160;Holder&#8217;s country of residence may modify the requirements described in this section. You should consult your own tax advisors regarding these rules and whether they may be relevant to your purchase, ownership and disposition of Class&#160;A Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The withholding obligations under FATCA generally apply to dividends on Class&#160;A Common Stock and to the payment of gross proceeds of a sale or other disposition of Class&#160;A Common Stock. However, the U.S. Treasury Department has issued proposed regulations that, if finalized in their present form, would eliminate FATCA withholding on gross proceeds of the sale or other disposition of Class&#160;A Common Stock (but not on payments of dividends). Taxpayers may rely on the proposed regulations until final regulations are issued or until such proposed regulations are rescinded. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">27<br></div></div></div>
<!--End Page 30-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 31-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_111-tax_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Information Reporting and Backup Withholding </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Information returns will be filed with the IRS in connection with payments of dividends and the proceeds from a sale or other disposition of our shares of Class&#160;A Common Stock. Backup withholding may also apply if the holder fails to provide certification of exempt status or a correct U.S. taxpayer identification number and otherwise comply with the applicable backup withholding requirements (including claims to a reduced rate of withholding under a treaty). Generally, a holder will not be subject to backup withholding if it provides a properly completed and executed IRS Form&#160;W-9 certifying no withholding is required or appropriate IRS Form&#160;W-8, as applicable. Backup withholding is not an additional tax. The amount of any backup withholding from a payment to a Non-U.S. Holder will be allowed as a credit against such holder&#8217;s U.S. federal income tax liability and may entitle such holder to a refund, provided that the required information is timely furnished to the IRS. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">THE SUMMARY OF CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS ABOVE IS INCLUDED FOR GENERAL INFORMATION PURPOSES ONLY. POTENTIAL PURCHASERS OF OUR COMMON STOCK ARE URGED TO CONSULT THEIR TAX ADVISORS TO DETERMINE THE U.S.&#160;FEDERAL, STATE AND LOCAL AND NON-U.S. INCOME, ESTATE AND OTHER TAX CONSIDERATIONS OF OWNING AND DISPOSING OF OUR COMMON STOCK.<font style="font-weight: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">28<br></div></div></div>
<!--End Page 31-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 32-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_112-legal_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Paul Hastings LLP has passed upon the validity of the securities of BRC Inc. offered by this prospectus and certain other legal matters related to this prospectus. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tEXP"><!--Anchor--></a>EXPERTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The consolidated financial statements of BRC Inc. appearing in BRC Inc.&#8217;s Annual Report (Form 10-K) for the year ended December 31, 2025, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have filed with the SEC a registration statement on Form&#160;S-3, including exhibits, with respect to the securities offered hereby. This prospectus, which forms a part of such registration statement, does not contain all of the information included in the registration statement. For further information pertaining to us and our securities, you should refer to the registration statement and to its exhibits. The registration statement has been filed electronically and may be obtained in any manner listed below. Whenever we make reference in this prospectus to any of our contracts, agreements or other documents, the references are not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement or a report we file under the Exchange Act, you should refer to the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit to a registration statement or report is qualified in all respects by the filed exhibit. You may review a copy of the registration statement through the SEC&#8217;s website at <font style="font-style: italic;">www.sec.gov</font>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the internet at the SEC&#8217;s website at <font style="font-style: italic;">www.sec.gov</font> and on our website at <font style="font-style: italic;">www.blackriflecoffee.com</font>. The information found on, or that can be accessed from or that is hyperlinked to, our website is not part of this prospectus. The information contained in or accessible from our website is not incorporated into this prospectus, and you should not consider it part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. You may access, free of charge, our annual reports on Form&#160;10-K, quarterly reports on Form&#160;10-Q, current reports on Form&#160;8-K and amendments to those reports filed or furnished pursuant to Section&#160;13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">29<br></div></div></div>
<!--End Page 32-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 33-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_300-part2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">PART II<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">INFORMATION NOT REQUIRED IN PROSPECTUS </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ITEM 14.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Other Expenses of Issuance and Distribution. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth the costs and expenses will be paid by us in connection with the issuance and distribution of the securities being registered. In addition, we may incur additional expenses in the future in connection with the offering of our securities pursuant to this prospectus. If required, any such additional expenses will be disclosed in a prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">All amounts are estimates, except for the SEC registration fee. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 396pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">SEC registration fee<font style="padding-left: 2.41pt;"></font></div></td><td style="width: 16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$6,041.88 </div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounting fees and expenses<font style="padding-left: 2.71pt;"></font></div></td><td style="width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">* </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Legal fees and expenses<font style="padding-left: 1.6pt;"></font></div></td><td style="width: 16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">* </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Printing fees<font style="padding-left: 2.68pt;"></font></div></td><td style="width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">* </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Miscellaneous fees and expenses<font style="padding-left: 1.61pt;"></font></div></td><td style="width: 16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"></font><font style="padding-bottom: 1.5pt;">* </font></div></td></tr><tr><td style="width: 396pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total expenses<font style="padding-left: 4.5pt;"></font></div></td><td style="width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 22.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;"> </font><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;"></font><font style="padding-bottom: 0.5pt;">*</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#8727;<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Fees and expenses will depend on the number and nature of any offerings of securities made pursuant to this registration statement, and cannot be estimated at this time. An estimate of the aggregate expenses in connection with the distribution of securities being offered will be included in any applicable prospectus supplement. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ITEM 15.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-style: italic;">Indemnification of Directors and Officers</font><font style="font-weight: normal;"> </font></div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The registrant is incorporated under the laws of the state of Delaware. Section&#160;145 of the General Corporation Law of the State of Delaware, (the &#8220;DGCL&#8221;), authorizes a corporation&#8217;s board of directors to grant, and authorizes a court to award, indemnity to officers, directors and other corporate agents. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The registrant&#8217;s amended and restated certificate of incorporation (as amended) and amended and restated by-laws (as amended) contain provisions that limit the liability of the registrant&#8217;s directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, the registrant&#8217;s directors will not be personally liable to the registrant or the registrant&#8217;s stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any breach of their duty of loyalty to the registrant or the registrant&#8217;s stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">with respect to directors, unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&#160;174 of the DGCL; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any transaction from which they derived an improper personal benefit. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of the registrant&#8217;s directors will be further limited to the greatest extent permitted by the DGCL. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The registrant&#8217;s amended and restated certificate of incorporation (as amended) and amended and restated by-laws (as amended) also provide that the registrant will indemnify, to the fullest extent permitted by law, each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that he or she is or was, or has agreed to become, a director or officer of the registrant, or is or was serving, or has agreed to serve, at the request of the registrant, as a director, officer, incorporator, employee or agent of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity. In addition, the registrant&#8217;s amended and restated certificate of incorporation and amended and restated by-laws provide that the registrant must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to very limited exceptions. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-1<br></div></div></div>
<!--End Page 33-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 34-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_300-part2_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, the registrant has entered into, and expects to continue to enter into, indemnification agreements with each of its directors and executive officers that may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements require the registrant, among other things, to indemnify its directors and executive officers against liabilities that may arise by reason of their status or service. These indemnification agreements also require the registrant to advance all expenses incurred by the directors and executive officers in investigating or defending any such action, suit or proceeding, subject to certain exceptions. The registrant believes that these agreements are necessary to attract and retain qualified individuals to serve as directors and executive officers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The limitation of liability and indemnification provisions that are included in the registrant&#8217;s amended and restated certificate of incorporation (as amended) and amended and restated by-laws (as amended) and in indemnification agreements that the Registrant enters into with its directors and executive officers may discourage stockholders from bringing a lawsuit against its directors and executive officers for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against the registrant&#8217;s directors and executive officers even though an action, if successful, might benefit the registrant and other stockholders. Further, a stockholder&#8217;s investment may be adversely affected to the extent that the registrant pays the costs of settlement and damage awards against directors and executive officers as required by these indemnification provisions. Except as may be disclosed this Registration Statement or the documents incorporated by reference herein, the registrant is not aware of any pending litigation or proceeding involving any person who is or was one of its directors, officers, employees or other agents or is or was serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, for which indemnification is sought, and the registrant is not aware of any threatened litigation that may result in claims for indemnification. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The registrant&#8217;s amended and restated by-laws (as amended) provide that the registrant may purchase and maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL. The registrant has obtained insurance under which, subject to the limitations of the insurance policies, coverage is provided to the registrant&#8217;s directors and executive officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or executive officer, including claims relating to public securities matters, and to the registrant with respect to payments that may be made by the registrant to these directors and executive officers pursuant to the registrant&#8217;s indemnification obligations or otherwise as a matter of law. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ITEM 16.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-style: italic;">Exhibits and Financial Statement Schedules.</font><font style="font-weight: normal;"> </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 414pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 48pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exhibit&#160;No.</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description of Exhibits </div></td></tr><tr><td style="width: 48pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1836707/000110465921136588/brrc-20211109xs4.htm#ANNEXA">2.1</a>#</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Business Combination Agreement, dated as of November&#160;2, 2021, by and among SilverBox, the Company, Merger Sub 1, Merger Sub 2, Authentic Brands and Blocker (incorporated by reference to Exhibit&#160;2.1 to the Company&#8217;s Form&#160;8-K filed on February&#160;10, 2022 with the SEC). </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1836707/000110465922000975/tm2131392-10_s4a.htm#tANXA">2.2</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">First Amendment to Business Combination Agreement, dated as of January&#160;4, 2022, by and among SilverBox, the Company, Merger Sub 1, Merger Sub 2, Authentic Brands and Blocker (incorporated by reference to Exhibit&#160;2.1 to the Company&#8217;s Registration Statement on Form&#160;S-4/A (File No. 333-260942) filed on January&#160;4, 2022 with the SEC). </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1891101/000110465922019525/tm223251d1_ex4-1.htm">4.1</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Specimen Common Stock Certificate (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Form&#160;8-K filed on February&#160;10, 2022 with the SEC). </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.2&#8224;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Specimen Preferred Stock Certificate and Form&#160;of Certificate of Designation of Preferred Stock </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.3&#8224;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Warrant Agreement (including form of Warrant Certificate) </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.4&#8224;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Subscription Rights Agreement </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.5&#8224;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Unit Agreement </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20068427x1_ex5-1.htm">5.1*</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Opinion of Paul Hastings LLP. </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20068427x1_ex23-1.htm">23.1*</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Ernst &amp; Young LLP. </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20068427x1_ex5-1.htm">23.2*</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Paul Hastings LLP (included in Exhibit&#160;5.1 to this Registration Statement) </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOWER">24</a>*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Power of Attorney (included on signature page) </div></td></tr><tr><td style="width: 48pt; padding-top: 0.51pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20068427x1_ex107.htm">107*</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 0.51pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Filing Fee Table</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 414pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#8727;<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Filed herewith. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">#<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Schedules and similar attachments to this Exhibit&#160;have been omitted pursuant to Item&#160;601(a)(5) of Registration S-K. The Company hereby agrees to furnish a copy of any omitted schedules to the SEC upon request.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#8224;<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">To be filed by amendment or as an exhibit to a Current Report on Form&#160;8-K and incorporated herein by reference, if applicable. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-2<br></div></div></div>
<!--End Page 34-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 35-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_300-part2_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ITEM 17.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-style: italic;">Undertakings</font>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. <font style="font-style: italic;">Provided, however</font>, that the undertakings set forth in paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is a part of the registration statement. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">If the registrant is relying on Rule&#160;430B: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(A)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Each prospectus filed by the registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(B)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-3<br></div></div></div>
<!--End Page 35-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 36-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_300-part2_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: (i) any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; (ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; (iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv) any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&#160;15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">That, for purposes of determining any liability under the Securities Act of 1933: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule&#160;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&#160;424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(8)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-4<br></div></div></div>
<!--End Page 36-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 37-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_301-sig_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">SIGNATURES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the requirements of the Securities Act, the Registrant has duly caused this Registration Statement on Form&#160;S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in West Valley City, State of Utah, on the 25th day of March&#160;2026. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 216pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 240pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 216pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">BRC INC.<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Christopher Mondzelewski </div></td></tr><tr><td style="width: 240pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Christopher Mondzelewski </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer and Director</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;"><a name="tPOWER"><!--Anchor--></a>POWER OF ATTORNEY </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">KNOW ALL PERSONS BY THESE PRESENTS<font style="font-weight: normal;">, that each person whose signature appears below constitutes and appoints Christopher Mondzelewski and Matthew Amigh, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, with full power of each to act alone, with full powers of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and generally to do all such things in their names and behalf in their capacities as officers and directors to enable BRC Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or any of them or their or his or her substitutes or resubstitutes, may lawfully do or cause to be done by virtue hereof. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dated indicated. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 144pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Signature</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date </div></td></tr><tr><td style="width: 144pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Christopher Mondzelewski</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Chief Executive Officer and Director <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"><font style="font-style: italic;">(Principal Executive Officer)</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25,2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Christopher Mondzelewski </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Matthew Amigh</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Chief Financial Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"><font style="font-style: italic;">(Principal Financial Officer)</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25,2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Matthew Amigh </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Robert Lee</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Vice President of Finance and Chief Accounting Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"><font style="font-style: italic;">(Principal Accounting Officer)</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25,2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Robert Lee </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Evan Hafer</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director and Executive Chairman </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Evan Hafer </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Lawrence Molloy</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25,2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Lawrence Molloy </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Katy Dickson</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25,2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Katy Dickson </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Clayton Hutmacher</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25,2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Clayton Hutmacher </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-5<br></div></div></div>
<!--End Page 37-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 38-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20068427x1_s3_301-sig_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 144pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Signature</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date </div></td></tr><tr><td style="width: 144pt; height: 15.25pt; padding-top: 2.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Steven Taslitz</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 15.25pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 15.25pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25,2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Steven Taslitz </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Glenn Welling</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Glenn Welling </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Stephen Kadenacy</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Stephen Kadenacy </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Sean Moriarty</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Sean Moriarty </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Melvin Landis</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 14pt; padding-top: 1.01pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;25, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Melvin Landis</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-6<br></div></div></div>
<!--End Page 38-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ny20068427x1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 5.1</div>
    <div><br>
    </div>
    <div><img src="ny20068427x1_ex5-1img01.jpg" height="53" width="181"></div>
    <div><br>
    </div>
    <div>March 25, 2026</div>
    <div><br>
    </div>
    <div>BRC Inc.</div>
    <div style="text-indent: -36pt; margin-left: 36pt;">3131 W. 2210 S., Suite C</div>
    <div style="text-indent: -36pt; margin-left: 36pt;">West Valley City, UT 84119</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z33b6c2a490d84061b2ee6b0bcef58365" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 36pt; vertical-align: top;">Re:</td>
          <td style="width: auto; vertical-align: top;">
            <div>Registration Statement on Form S-3</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">We have acted as counsel to BRC Inc., a Delaware corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), in connection with the preparation and filing on the date
      hereof with the U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221;) of a registration statement on Form S-3 (the &#8220;<font style="font-weight: bold; font-style: italic;">Registration
        Statement</font>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Act</font>&#8221;).&#160; You have provided us with a draft of the Registration Statement in the form in which it will be filed, which
      includes a base prospectus (the &#8220;<font style="font-weight: bold; font-style: italic;">Prospectus</font>&#8221;), which provides that it will be supplemented in the future by one or more supplements to the Prospectus, free writing prospectuses or term
      sheets (each, a &#8220;<font style="font-weight: bold; font-style: italic;">Prospectus Supplement</font>).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">The Registration Statement and the Prospectus relate to the proposed issuance and sale from time to time, pursuant to Rule 415 of the rules and regulations promulgated under the Act, of up to
      $500,000,000 of (i) shares of the Company&#8217;s Class A common stock, par value $0.0001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Class A</font>&#160;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221;), (ii)
      shares of the Company&#8217;s preferred stock, par value $0.0001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Preferred Stock</font>&#8221;), (iii) subscription rights to purchase shares of Class A Common Stock or Preferred Stock (the &#8220;<font style="font-weight: bold; font-style: italic;">Subscription Rights</font>&#8221;), (iv) warrants to purchase Class A Common Stock or Preferred Stock (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Warrants</font>&#8221;), which may be
      issued under warrant agreements (each, a &#8220;<font style="font-weight: bold; font-style: italic;">Warrant Agreement</font>&#8221;), to be dated on or about the date of the first issuance of the applicable Warrants thereunder, by and between the Company and a
      warrant agent to be selected by the Company (the &#8220;<font style="font-weight: bold; font-style: italic;">Warrant Agent</font>&#8221;), and (v) units consisting of any combination of Class A Common Stock, Preferred Stock, Subscription Rights and/or Warrants
      (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Units</font>&#8221;), which may be issued under unit agreements by and between the Company and a unit agent to be selected by the Company (each, a &#8220;<font style="font-weight: bold; font-style: italic;">Unit Agreement</font>&#8221;). The Class A Common Stock, Preferred Stock, Subscription Rights, Warrants, and Units are collectively referred to herein as the &#8220;<font style="font-weight: bold; font-style: italic;">Securities</font>.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">This opinion letter is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the
      contents of the Registration Statement, the Prospectus or any Prospectus Supplement, other than as expressly stated herein with respect to the issuance of the Securities.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">As such counsel and for purposes of our opinions set forth herein, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of such documents,
      resolutions, certificates and other instruments of the Company and corporate records furnished to us by the Company, and have reviewed certificates of public officials, statutes, records and such other instruments and documents, and have made such
      investigations of law as we have deemed necessary or appropriate as a basis for the opinions set forth in this opinion letter.&#160; In such examination and in rendering the opinions expressed below, we have assumed, without independent investigation or
      verification: (i) the genuineness of all signatures on all agreements, instruments, corporate records, certificates and other documents submitted to us, (ii) the legal competency, capacity and authority of all persons or entities (other than the
      Company) executing all agreements, instruments, corporate records, certificates and other documents submitted to us, (iii) the authenticity and completeness of all agreements, instruments, corporate records, certificates and other documents submitted
      to us as originals, (iv) that all agreements, instruments, corporate records, certificates and other documents submitted to us as certified, electronic, facsimile, conformed, photostatic or other copies conform to the originals thereof, and that such
      originals are authentic and complete, (v) the due authorization, execution and delivery of all agreements, instruments, corporate records, certificates and other documents by all parties thereto (other than the Company), (vi) that no documents
      submitted to us have been amended or terminated orally or in writing, except as has been disclosed to us in writing, (vii) that the statements contained in the certificates and comparable documents of public officials, officers and representatives of
      the Company and other persons on which we have relied for the purposes of this opinion letter are true and correct on and as of the date hereof, (viii) that there has not been and there will not be any change in the good standing status of the
      Company from that which was reported in the certificate of good standing regarding the Company obtained from the Secretary of State of the State of Delaware, and (ix) that each of the officers and directors of the Company has properly exercised his
      or her fiduciary duties.&#160; As to all questions of fact material to this opinion letter and as to the materiality of any fact or other matter referred to herein, we have relied (without independent investigation or verification) upon representations
      and certificates or comparable documents of officers and representatives of the Company. Our knowledge of the Company and its legal and other affairs is limited by the scope of our engagement, which scope includes the delivery of this opinion letter.
      We do not represent the Company with respect to all legal matters or issues.&#160; The Company may employ other independent counsel and, to our knowledge, handles certain legal matters and issues without the assistance of independent counsel.</div>
    <div><br>
    </div>
    <div style="text-align: right;">Paul Hastings LLP&#160; |&#160; 1117 S. California Avenue&#160; |&#160; Palo Alto, California 94304</div>
    <div style="text-align: right;">T: + 1.650.320.1800&#160; |&#160; www.paulhastings.com</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div><img src="ny20068427x1_ex5-1img01.jpg" height="53" width="181"></div>
    </div>
    <div><br>
    </div>
    <div>BRC Inc.</div>
    <div>March 25, 2026</div>
    <div>Page 2</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">With your consent, we have assumed that (i) the Subscription Rights and any related Subscription Rights agreement, each of the Warrants and any related Warrant Agreement, the Units and any related
      Unit Agreement, and any purchase, underwriting, sales agreement or similar agreement (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Documents</font>&#8221;) will be governed by the internal laws of the State of New York and that
      the choice of law is legally enforceable, (ii) the Subscription Rights, Subscription Rights agreements, Warrants, Warrant Agreements, Units, and Unit Agreements, will contain all provisions required under the laws of the State of Delaware in respect
      of contracts for the sale of securities issued by a Delaware corporation, (iii) each of the Documents will be duly authorized, executed and delivered by the parties thereto other than the Company, and (iv)&#160; each of the Documents will constitute valid
      and binding obligations of the parties thereto other than the Company, enforceable against such parties in accordance with their respective terms.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">We also have assumed that none of (i) the execution, delivery and performance of any of the Documents, (ii) the terms of any of the Securities to be established after the date hereof, (iii) the
      issuance or delivery of such Securities, or (iv) the compliance by the Company with the terms of such Securities will (a) violate any applicable law, rule or regulation to which the Company is then subject or the Company&#8217;s Amended and Restated
      Certificate of Incorporation filed with the Secretary of State of the State of Delaware, as amended or restated from time to time (the &#8220;<font style="font-weight: bold; font-style: italic;">Certificate of Incorporation</font>&#8221;) or its amended and
      restated by-laws then in effect, (b) result in a breach of or default under any instrument or agreement then binding upon the Company or any of its properties, or (c) violate, or cause the Company not to comply with, any consent, approval, license,
      authorization, restriction or requirement imposed by, or any filing, recording or registration with, any court or governmental body having jurisdiction over the Company. We have also assumed that upon the issuance of any Class A Common Stock or
      Securities convertible into or exercisable for shares of Class A Common Stock, the total number of shares of Class A Common Stock issued and outstanding upon such issuance, conversion or exercise, respectively, will not exceed the total number of
      shares of Class A Common Stock that the Company is then authorized to issue under the Certificate of Incorporation.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">We have further assumed that (i) an appropriate Prospectus Supplement relating to the Securities offered thereby will have been prepared and filed with the Commission in compliance with the Act and
      will comply with all applicable laws at the time the Securities are offered and issued as contemplated by the Registration Statement, the Prospectus and such Prospectus Supplement, (ii) the terms of the Securities will conform to the descriptions
      thereof in the Registration Statement, the Prospectus, and any Prospectus Supplement, as applicable, and the corporate action of the Company authorizing the issuance and sale of such Securities, (iii) all Securities will be issued and sold in
      compliance with the applicable provisions of the Act, the Trust Indenture Act of 1939, as amended, if applicable, and the securities or blue sky laws of various states and in the manner stated in the Registration Statement, the Prospectus and any
      Prospectus Supplement, as applicable, and (iv) the number of shares of Class A Common Stock or Preferred Stock, as the case may be, offered pursuant to the Registration Statement, the Prospectus and any Prospectus Supplement, as applicable, or, in
      the case of Preferred Stock, Subscription Rights, Warrants, and Units, as applicable, represented by, comprising or issuable upon exchange, exercise or conversion of such Securities, does not exceed, at the time of issuance of such Securities, the
      authorized but unissued shares of Class A Common Stock or Preferred Stock, as the case may be.&#160; We have also assumed that the Registration Statement and any amendments thereto will have become effective under the Act (and such effectiveness shall not
      have been terminated or rescinded) and comply with all applicable laws at the time the Securities are offered and issued as contemplated by the Registration Statement, the Prospectus and any Prospectus Supplement, as applicable.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div>
        <div><img src="ny20068427x1_ex5-1img01.jpg" height="53" width="181"></div>
      </div>
      <div><br>
      </div>
      <div>BRC Inc.</div>
      <div>March 25, 2026</div>
      <div>Page 3<br>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Based upon the foregoing, and in reliance thereon, and subject to the assumptions, limitations, qualifications and exceptions set forth herein, it is our opinion that, as of the date hereof:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With respect to any shares of Class A Common Stock to be offered by the Company pursuant to the Registration Statement (including any shares of Class A Common Stock duly issued upon the
      exchange, exercise or conversion of Securities that are exchangeable or exercisable for, or convertible into, Class A Common Stock), when (i) the issuance of such shares of Class A Common Stock has been duly authorized by all necessary corporate
      action of the Company, and (ii) such shares of Class A Common Stock have been duly issued and delivered against payment of the consideration therefor (not less than the par value of the Class A Common Stock) as contemplated by the Registration
      Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, such shares of Class A Common Stock will be validly issued, fully paid and nonassessable.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With respect to any shares of Preferred Stock to be offered by the Company pursuant to the Registration Statement (including any shares of Preferred Stock duly issued upon the exchange,
      exercise or conversion of Securities that are exchangeable or exercisable for, or convertible into, Preferred Stock), when (i) a series of Preferred Stock has been duly established in accordance with the terms of the Certificate of Incorporation and
      applicable law and authorized by all necessary corporate action of the Company, (ii) the relative rights, preferences and limitations of such series of Preferred Stock have been designated by all necessary corporate action of the Company and set
      forth in a Certificate of Designation or amendment to the Certificate of Incorporation properly filed with the Secretary of State of the State of Delaware, (iii) the issuance of such shares of Preferred Stock has been duly authorized by all necessary
      corporate action of the Company, (iv) such shares of Preferred Stock have been duly issued and delivered against payment of the consideration therefor (not less than the par value of the Preferred Stock) as contemplated by the Registration Statement,
      the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (v) if such shares of Preferred Stock are convertible into shares of Class A Common Stock, such shares of Class A Common Stock have been
      duly authorized and reserved for issuance by all necessary corporate action of the Company, such shares of Preferred Stock will be validly issued, fully paid and nonassessable.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With respect to Subscription Rights to be offered by the Company pursuant to the Registration Statement, when (i) a subscription rights agreement has been duly authorized, executed and
      delivered by the Company and the subscription agent named therein, (ii) the specific terms of the particular issuance of Subscription Rights have been duly established in accordance with such subscription rights agreement and applicable law and
      authorized by all necessary corporate action of the Company, (iii) the Subscription Rights have been duly executed, countersigned, issued and delivered against payment therefor in accordance with such subscription rights agreement and as contemplated
      by the Registration Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (iv) the shares of Class A Common Stock or Preferred Stock relating to such Subscription Rights, as
      applicable, have been duly authorized and reserved for issuance by all necessary corporate action of the Company and in accordance with the terms of the Subscription Rights and the Subscription Rights agreement, such Subscription Rights will
      constitute binding obligations of the Company, enforceable against the Company in accordance with their terms.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div>
        <div><img src="ny20068427x1_ex5-1img01.jpg" height="53" width="181"></div>
      </div>
      <div><br>
      </div>
      <div>BRC Inc.</div>
      <div>March 25, 2026</div>
      <div>Page 4<br>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With respect to any Warrants to be offered by the Company pursuant to the Registration Statement, when (i) a warrant agreement has been duly authorized, executed and delivered by the
      Company and the Warrant Agent named therein, (ii) the specific terms of the particular issuance of Warrants have been duly established in accordance with such Warrant Agreement and applicable law and authorized by all necessary corporate action of
      the Company, (iii) the Warrants have been duly executed, countersigned, issued and delivered against payment therefor in accordance with such warrant agreement and as contemplated by the Registration Statement, the Prospectus, any applicable
      Prospectus Supplement, any applicable Documents and such corporate action, and (iv) as applicable, the shares of Class A Common Stock or Preferred Stock issuable upon exercise of the Warrants have been duly authorized and reserved for issuance upon
      exercise of the Warrants, by all necessary corporate action of the Company and in accordance with the terms of the Warrants and the warrant agreement, such Warrants will constitute binding obligations of the Company, enforceable against the Company
      in accordance with their terms.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With respect to any Units to be offered by the Company pursuant to the Registration Statement, when (i) the applicable Unit Agreement has been duly authorized, executed and delivered by
      all necessary corporate action of the Company and the counterparty named therein, (ii) the specific terms of the particular issuance of Units have been duly established in accordance with such Unit Agreement and applicable law and authorized by all
      necessary corporate action of the Company, (iii) the Units have been duly executed, countersigned, issued and delivered against payment of the consideration therefor in accordance with such Unit Agreement and as contemplated by the Registration
      Statement, the Prospectus, any applicable Prospectus Supplement, any applicable Documents and such corporate action, and (iv) as applicable, (a) the shares of Class A Common Stock or Preferred Stock (1) comprising the Units, (2) underlying the
      Warrants comprising the Units and/or (3) relating to the Subscription Rights comprising the Units have been duly authorized and reserved for issuance and/or (b) the Warrants issuable upon exercise of such Units have been duly authorized, executed and
      authenticated in accordance with the provisions of the applicable Indenture or Warrant Agreement and reserved for delivery upon exercise of the Units, and/or (c) the Warrants comprising such Units have been duly executed, countersigned, issued and
      delivered in accordance with the applicable Warrant Agreement, and/or (d) the Subscription Rights comprising such Units have been duly executed, countersigned, issued and delivered in accordance with the applicable Subscription Rights agreement, in
      each case by all necessary corporate action of the Company and in accordance with the terms of the Units and the Unit Agreement, such Units will constitute binding obligations of the Company, enforceable against the Company in accordance with their
      terms.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Our opinions are subject to (i) the effect of any bankruptcy, insolvency, reorganization, moratorium or similar laws and principles affecting creditors&#8217; rights generally (including, without
      limitation, fraudulent transfer or fraudulent conveyance laws), and (ii) the effect of general principles of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) and the availability of
      equitable remedies (including, without limitation, specific performance and equitable relief), regardless of whether considered in a proceeding in equity or at law.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Without limiting any of the other limitations, exceptions and qualifications stated elsewhere herein, we express no opinion as to any provision (i) that could be construed as a penalty or forfeiture,
      (ii) indemnifying a party against liability for its own wrongful or negligent acts or otherwise in cases where indemnification or contribution could be considered contrary to public policy (including, without limitation, under federal and state
      securities laws and regulations as interpreted by applicable governmental authorities), (iii) exculpating another party from liability or waiving defenses or other rights, (iv) to the effect that terms of a document may not be waived or modified
      except in writing, (v) regarding the recovery of attorneys&#8217; fees for a person who is not the prevailing party in a final proceeding, (vi) imposing a payment obligation with respect to the Company&#8217;s obligations, or (vii) whereby a party purports to
      ratify acts in advance of the occurrence of such acts.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div>
        <div><img src="ny20068427x1_ex5-1img01.jpg" height="53" width="181"></div>
      </div>
      <div><br>
      </div>
      <div>BRC Inc.</div>
      <div>March 25, 2026</div>
      <div>Page 5<br>
      </div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">We express no opinion with respect to the validity or enforceability of (i) any provision allowing any party to exercise any remedial rights without notice to the Company, (ii) any waiver of demand
      by the Company or any waiver of any rights or any defense that as a matter of law or public policy cannot be waived, (iii) any provision purporting to establish evidentiary standards, (iv) any provision that purports to establish the subject matter
      jurisdiction of the United States District Court to adjudicate any controversy, (v) any provision that purports to entitle any person or entity to specific performance of any provision of such document, (vi) any provision that requires a person or
      entity to cause another person or entity to take or to refrain from taking action under circumstances in which such person or entity does not control such other person or entity, (vii) any provision insofar as it purports to effect a choice of
      governing law or choice of forum for the adjudication of disputes, (viii) any provision to the extent that it requires that a claim with respect to a security denominated in other than U.S. dollars (or a judgment in respect of such a claim) be
      converted into U.S. dollars at a rate of exchange at a particular date, to the extent applicable law otherwise provides, or (ix) the effectiveness of service of process by mail in any suit, action or proceeding of any nature. Further, we express no
      opinion as to the acceptance by a federal court located in the State of New York of jurisdiction of a dispute arising under any Document.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">We express no opinion as to the validity or enforceability of any provision that (i) waives (a) vague or broadly stated rights, (b) future rights, (c) the benefits of statutory, regulatory or
      constitutional rights, unless and to the extent that the statute, regulation or constitution expressly allows waiver, (d) unknown future defenses, or (e) rights to damages, (ii) states that rights or remedies are not exclusive, that every right or
      remedy is cumulative and may be exercised in addition to any other right or remedy, that the election of some particular remedy does not preclude recourse to one or more others or that the failure to exercise or delay in exercising rights or remedies
      will not operate as a waiver of any such right or remedy, (iii) grants set-off rights, (iv) imposes penalties, forfeitures, late payment charges or an increase in interest rate upon delinquency in payment or the occurrence of a default, (v) appoints
      one party as an attorney-in-fact for an adverse party or (vi) states that time is of the essence.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">Without limiting any of the other limitations, exceptions and qualifications stated elsewhere herein, we express no opinion with regard to the applicability or effect of the laws of any jurisdiction
      other than, with respect to any shares of Class A Common Stock and Preferred Stock, the General Corporation Law of the State of Delaware and, with respect to the Documents, the internal laws of the State of New York, in each case as in effect on the
      date hereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">This opinion letter deals only with the specified legal issues expressly addressed herein, and you should not infer any opinion that is not explicitly stated herein from any matter addressed in this
      opinion letter.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">This opinion letter is rendered solely in connection with the Registration Statement. This opinion letter is rendered as of the date hereof, and we assume no obligation to advise you or any other
      person with regard to any change after the date hereof in the circumstances or the law that may bear on the matters set forth herein even if the change may affect the legal analysis or a legal conclusion or other matters in this opinion letter. We
      hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement and to the reference to our firm in the Prospectus under the heading &#8220;Legal Matters&#8221;. In giving such consent, we do not hereby admit that we are within
      the category of persons whose consent is required under Section 7 of the Act or the rules or regulations of the Commission promulgated thereunder.</div>
    <div><br>
    </div>
    <div>Very truly yours,</div>
    <div><br>
    </div>
    <div>/s/ Paul Hastings LLP</div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ny20068427x1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 23.1</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: center; margin-left: 11.25pt; color: #333333; font-weight: bold;">Consent of Independent Registered Public Accounting Firm</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; color: rgb(51, 51, 51);">We consent to the reference to our firm under the caption "Experts" in this Registration Statement (Form S-3) and related Prospectus of BRC Inc. for the registration of $500,000,000 of
          Class A common stock, preferred stock, subscription rights, warrants, and units, and to the incorporation by reference therein of our report dated March 2, 2026, with respect to the consolidated financial statements of BRC Inc. included in its
          Annual Report (Form 10-K) for the year ended December 31, 2025, filed with the Securities and Exchange Commission.</div>
      </div>
      <div><br>
      </div>
      <div>/s/ Ernst &amp; Young LLP</div>
      <div><br>
      </div>
      <div>San Antonio, Texas</div>
      <div><br>
      </div>
      <div>March 25, 2026</div>
      <div><br>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><br>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ny20068427x1_ex107.htm
<DESCRIPTION>FILING FEES TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Mar 25 16:10:22 UTC 2026 -->
<!-- Created by CompSci Resources, LLC on Mon Oct 13 19:35:23 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
 <body><div style="font-family: Times New Roman; font-size: 12pt;"><div>

  </div><hr style="border-top: 4px solid black; border-bottom: none; border-left: none; border-right: none; height: 2px; margin: 8px auto; width: 100%;"/><div style="text-align: right; margin-right: 0.75pt;">
   <span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Exhibit 107</span>
  </div><div>

  </div><div style="margin-bottom: 10pt; margin-top: 10pt; text-align: center;">
   <span style="font-size: 10.0pt; font-weight: bold;"><b>Calculation of Filing Fee Tables</b></span>
  </div><div>
  </div><div style="text-align: center;"> <span style="font-size: 10pt; font-weight: bold;"><b><span style="text-decoration:underline">Form <ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-374"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-375">S-3</ix:nonNumeric></ix:nonNumeric></span></b></span> </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000;">(Form Type)</span>
  </div><div>
  </div><div style="text-align: center; font-size: 10pt;">&#160;
  </div><div>

  </div><div style="text-align: center;"> <ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-26"><span style="font-size: 10pt; font-weight: bold;"><b><span style="text-decoration:underline">BRC Inc.</span></b></span></ix:nonNumeric> </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000;">(Exact Name of Registrant as Specified in its Charter)</span>
  </div><div>
  </div><div style="text-align: center; margin-right: 0.75pt; font-size: 10pt;">&#160;
  </div><div>
  </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000; font-weight: bold; text-decoration: underline;">Table 1: Newly Registered and Carry Forward Securities</span>
  </div><div>
















  </div><table style="border-spacing: 0px; border-collapse: collapse; margin-left: -0.25pt; width: 100%; font-size: 10pt;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 9%;">&#160;</td><td style="width: 1%;">&#160;</td><td style="width: 9%;">&#160;</td><td style="width: 11%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td><td style="width: 7%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Security Type</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 2pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Security Class Title</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 2pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Fee Calculation or Carry Forward Rule</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Amount Registered</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Proposed Maximum Offering Price Per Unit</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Maximum Aggregate Offering Price</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; white-space: nowrap;"> <span style="font-weight: bold;">Fee Rate</span> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Amount of Registration Fee</span> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Carry Forward Form Type</span> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Carry Forward <br/>File Number</span> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Carry Forward Initial Effective Date</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</span> </td> </tr> <tr style="vertical-align: top;"> <td colspan="14" style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: center;"> <span style="font-weight: bold;">Newly Registered Securities</span> </td> </tr> <tr style="vertical-align: top; height: 11pt; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; height: 11pt;"> <div> <ix:nonNumeric contextRef="c1" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-376">Fees to Be Paid</ix:nonNumeric> </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTp" id="ixv-377">Equity</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTitl" id="ixv-378">Class A Common Stock,
$0.0001 par value per share</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c1" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-379">457(o)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr><tr style="vertical-align: top; height: 11pt;"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; height: 11pt;"> <div> <ix:nonNumeric contextRef="c2" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-380">Fees to Be Paid</ix:nonNumeric> </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c2" name="ffd:OfferingSctyTp" id="ixv-381">Equity</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c2" name="ffd:OfferingSctyTitl" id="ixv-382">Preferred Stock, $0.0001
par value per share</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c2" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-383">457(o)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr><tr style="vertical-align: top; height: 11pt; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; height: 11pt;"> <div> <ix:nonNumeric contextRef="c3" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-384">Fees to Be Paid</ix:nonNumeric> </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c3" name="ffd:OfferingSctyTp" id="ixv-385">Other</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c3" name="ffd:OfferingSctyTitl" id="ixv-386">Subscription Rights</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c3" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-387">457(o)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr><tr style="vertical-align: top; height: 11pt;"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; height: 11pt;"> <div> <ix:nonNumeric contextRef="c4" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-388">Fees to Be Paid</ix:nonNumeric> </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c4" name="ffd:OfferingSctyTp" id="ixv-389">Other</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c4" name="ffd:OfferingSctyTitl" id="ixv-390">Warrants</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c4" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-391">457(o)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr><tr style="vertical-align: top; height: 11pt; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; height: 11pt;"> <div> <ix:nonNumeric contextRef="c5" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-392">Fees to Be Paid</ix:nonNumeric> </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c5" name="ffd:OfferingSctyTp" id="ixv-393">Other</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c5" name="ffd:OfferingSctyTitl" id="ixv-394">Units</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c5" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-395">457(o)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr><tr style="vertical-align: top; height: 11pt;"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; height: 11pt;"> <div> <ix:nonNumeric contextRef="c6" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-396">Fees to Be Paid</ix:nonNumeric> </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">(1)</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;">
<ix:nonNumeric contextRef="c6" name="ffd:OfferingSctyTp" id="ixv-397">Unallocated (Universal) Shelf</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <span style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">&#8212;</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c6" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-398">457(o)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-399">43,750,000</ix:nonFraction> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-400">0.00013810</ix:nonFraction> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-401">6,041.88</ix:nonFraction> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr> <tr style="vertical-align: top; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;"> <div> Fees Previously Paid </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#8212; </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#8212; </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#8212; </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#8212; </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#8212; </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#8212; </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#8212; </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> </tr> <tr style="vertical-align: top;"> <td colspan="14" style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: center;"> <span style="font-weight: bold;">Carry Forward Securities</span> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;"> <div> Carry Forward Securities </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c7" name="ffd:OfferingSctyTp" id="ixv-402">Equity</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c7" name="ffd:OfferingSctyTitl" id="ixv-403">Class A Common Stock,
$0.0001 par value per share</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c7" format="ixt:fixed-true" name="ffd:Rule415a6Flg" id="ixv-404">415(a)(6)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c7" name="ffd:CfwdFormTp" id="ixv-405">S-3</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c7" name="ffd:CfwdPrrFileNb" id="ixv-406">333-270727</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c7" format="ixt:date-month-day-year" name="ffd:CfwdPrrFctvDt" id="ixv-407">3/30/2023</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> &#160;</td> </tr><tr style="vertical-align: top;"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;"> <div> Carry Forward Securities </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c8" name="ffd:OfferingSctyTp" id="ixv-408">Equity</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c8" name="ffd:OfferingSctyTitl" id="ixv-409">Preferred Stock, $0.0001
par value per share</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c8" format="ixt:fixed-true" name="ffd:Rule415a6Flg" id="ixv-410">415(a)(6)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c8" name="ffd:CfwdFormTp" id="ixv-411">S-3</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c8" name="ffd:CfwdPrrFileNb" id="ixv-412">333-270727</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c8" format="ixt:date-month-day-year" name="ffd:CfwdPrrFctvDt" id="ixv-413">3/30/2023</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> &#160;</td> </tr><tr style="vertical-align: top; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;"> <div> Carry Forward Securities </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c9" name="ffd:OfferingSctyTp" id="ixv-414">Other</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c9" name="ffd:OfferingSctyTitl" id="ixv-415">Subscription Rights</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c9" format="ixt:fixed-true" name="ffd:Rule415a6Flg" id="ixv-416">415(a)(6)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c9" name="ffd:CfwdFormTp" id="ixv-417">S-3</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c9" name="ffd:CfwdPrrFileNb" id="ixv-418">333-270727</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c9" format="ixt:date-month-day-year" name="ffd:CfwdPrrFctvDt" id="ixv-419">3/30/2023</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> &#160;</td> </tr><tr style="vertical-align: top;"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;"> <div> Carry Forward Securities </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c10" name="ffd:OfferingSctyTp" id="ixv-420">Other</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c10" name="ffd:OfferingSctyTitl" id="ixv-421">Warrants</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c10" format="ixt:fixed-true" name="ffd:Rule415a6Flg" id="ixv-422">415(a)(6)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c10" name="ffd:CfwdFormTp" id="ixv-423">S-3</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c10" name="ffd:CfwdPrrFileNb" id="ixv-424">333-270727</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c10" format="ixt:date-month-day-year" name="ffd:CfwdPrrFctvDt" id="ixv-425">3/30/2023</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> &#160;</td> </tr><tr style="vertical-align: top; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;"> <div> Carry Forward Securities </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c11" name="ffd:OfferingSctyTp" id="ixv-426">Other</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c11" name="ffd:OfferingSctyTitl" id="ixv-427">Units</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c11" format="ixt:fixed-true" name="ffd:Rule415a6Flg" id="ixv-428">415(a)(6)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c11" name="ffd:CfwdFormTp" id="ixv-429">S-3</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c11" name="ffd:CfwdPrrFileNb" id="ixv-430">333-270727</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c11" format="ixt:date-month-day-year" name="ffd:CfwdPrrFctvDt" id="ixv-431">3/30/2023</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> &#160;</td> </tr><tr style="vertical-align: top;"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;"> <div> Carry Forward Securities </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">(2)</td><td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;">
<ix:nonNumeric contextRef="c12" name="ffd:OfferingSctyTp" id="ixv-432">Unallocated (Universal) Shelf</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <span style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">&#8212;</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c12" format="ixt:fixed-true" name="ffd:Rule415a6Flg" id="ixv-433">415(a)(6)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-434">456,250,000</ix:nonFraction> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> &#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c12" name="ffd:CfwdFormTp" id="ixv-435">S-3</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c12" name="ffd:CfwdPrrFileNb" id="ixv-436">333-270727</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c12" format="ixt:date-month-day-year" name="ffd:CfwdPrrFctvDt" id="ixv-437">3/30/2023</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> $<ix:nonFraction contextRef="c12" decimals="2" format="ixt:num-dot-decimal" name="ffd:CfwdPrevslyPdFee" scale="0" unitRef="usd" id="ixv-438">50,278.75</ix:nonFraction> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204, 238, 255);"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black;">&#160;</td> <td colspan="5" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; vertical-align: bottom;"> <span style="font-weight: bold;">Total Offering Amounts</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ffd:TtlOfferingAmt" scale="0" unitRef="usd" id="ixv-439">500,000,000</ix:nonFraction> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlFeeAmt" scale="0" unitRef="usd" id="ixv-440">6,041.88</ix:nonFraction> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px;">&#160;</td> </tr> <tr style="vertical-align: top;"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black;">&#160;</td> <td colspan="5" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; vertical-align: bottom;"> <span style="font-weight: bold;">Total Fees Previously Paid</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonFraction contextRef="c0" decimals="0" format="ixt:fixed-zero" name="ffd:TtlPrevslyPdAmt" scale="0" unitRef="usd" id="ixv-441">&#8212;</ix:nonFraction> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; text-align: center;">&#160;</td> </tr> <tr style="vertical-align: top; height: 11pt; background-color: rgb(204, 238, 255);"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; height: 11pt;">&#160;</td> <td colspan="5" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; height: 11pt; vertical-align: bottom;"> <span style="font-weight: bold;">Total Fee Offsets</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonFraction contextRef="c0" decimals="0" format="ixt:fixed-zero" name="ffd:TtlOffsetAmt" scale="0" unitRef="usd" id="ixv-442">&#8212;</ix:nonFraction> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 1.75pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr> <tr style="vertical-align: top; height: 11pt;"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; height: 11pt;">&#160;</td> <td colspan="5" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; height: 11pt; vertical-align: bottom;"> <span style="font-weight: bold;">Net Fee Due</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NetFeeAmt" scale="0" unitRef="usd" id="ixv-443">6,041.88</ix:nonFraction> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.5pt 2pt 1px; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> </tr> </table><ix:nonNumeric contextRef="c6" escape="true" name="ffd:OfferingNote" id="ixv-346"><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">(1)</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> There are being registered
hereunder such indeterminate amount of Class A common stock, preferred stock,
warrants to purchase common stock or preferred stock, subscription rights to
purchase common stock, preferred stock, units and other securities and units as
may be sold by the Registrant from time to time, which together shall have an
aggregate initial offering price not to exceed $500,000,000. The Registrant
will determine, from time to time, the proposed maximum offering price per unit
in connection with its issuance of the securities the Registrant is registering
under this registration statement. The securities registered also include such
indeterminate number of shares of Class A common stock and preferred stock as
may be issued upon conversion of or exchange for preferred stock that provide
for conversion or exchange, upon exercise of warrants or pursuant to the
antidilution provisions of any such securities. In addition, pursuant to Rule
416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the
shares being registered hereunder include such indeterminate number of shares
of common stock and preferred stock as may be issuable with respect to the
shares being registered hereunder as a result of stock splits, stock dividends
or similar transactions.<br/><br/>The proposed maximum
aggregate offering price per unit will be determined from time to time by the Registrant
in connection with the issuance by the Registrant of the securities registered
hereunder and is not specified as to each class of security pursuant to pursuant
to Item 16(b) of Form&#160;S-3&#160;under the Securities Act. The proposed
maximum aggregate offering price has been estimated solely for the purpose of
calculating the registration fee pursuant to Rule 457(o) under the Securities
Act of 1933, as amended. </div> </td> </tr> </table></ix:nonNumeric><ix:nonNumeric contextRef="c12" escape="true" name="ffd:OfferingNote" id="ixv-359"><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">(2)</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> The Registrant previously registered the offer
and sale of securities having a maximum aggregate offering price of $500,000,000
pursuant to a registration statement on Form S-3 (File No. 333-270727)
initially filed with the Securities and Exchange Commission on July 18, 2025
(the &#8220;Prior Registration Statement&#8221;) and, in connection therewith, paid a
filing fee of $55,100. Of such securities, an aggregate of $461,500,000 remain
unsold (the &#8220;Unsold Securities&#8221;). Pursuant to Rule 415(a)(6) under the
Securities Act, the securities registered pursuant to this registration
statement include the Unsold Securities, and the filing fee of $50,857.30 associated
therewith (which amount is based on the filing fee rate in effect at the time
of the filing of the Prior Registration Statement) is hereby carried forward to
be applied to the Unsold Securities and no additional filing fee is due with
respect to such Unsold Securities in connection with the filing of this
registration statement. Pursuant to Rule 415(a)(6), the offering of the Unsold
Securities pursuant to the Prior Registration Statement shall be deemed
terminated as of the date of the effective date of this registration statement. </div> </td> </tr> </table></ix:nonNumeric><div style="margin-right : 171.75pt; font-size : 8pt; width : 100%; ">&#160;
  </div><div>

 </div><hr style="border-top: 2px solid black; border-bottom: none; border-left: none; border-right: none; height: 2px; margin: 8px auto; width: 100%;"/><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-446">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-447">0001891101</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-448">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-449">N/A</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>1</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>2</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>3</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>4</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>5</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>6</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>7</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>8</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>9</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>10</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>11</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001891101</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>12</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV6][uwVPlSLqm6MZwDlza/tbbLF2lhLrECH8xM5zU2IQtfu5fP6gOAOna/UmiyjsFlwUUc0RQHl8H6tBq4+PNUbsBSm+ICm9rI5DNGkvm48Dx/50e16qh6Ic/Sq9HNqC42CWpC6aEMr3xRvRMyEV2Dw9vUbZslUL2xSm91GHeSDaL4Hk9fWvHb8qbVV+SGwYmM3Np252iff5+CQPlyEnVHpQarKANEEKZHerBWor8cXem1fpnJZjtSk3HAYDxYwn5SoVqU9gR+CxV4H/+fbpw9mVuULdQE/wT+IFoskxRYdeRZ/+aD8/CcjGlwhqBunK6V2fuEZMP8Un0LKtGy779+fWwJhq2bkwTI6g] CSR-->
  <xbrli:period>
    <xbrli:startDate>2026-03-25</xbrli:startDate>
    <xbrli:endDate>2026-03-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo_brc1.jpg
<TEXT>
begin 644 logo_brc1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M  2F^*7P^^#?Q"^$WQ0^+GCKQYX'D^(3VO@2[\,:5IGAWP_)K-]H6E_VG?\
MB'4()9K[5+W2=4>*VLK*9+>VM%EGG#SQQ5^3+?\ !YW^S.&.W]BWXZ%<G!;X
M@^ %8CL2HM6 /J S8]37Y*_\'@KAO^"DOPH0=4_92\$[O^!?$+XF,/TK^:?]
MG[]GSXQ?M3?%GPK\#?@)X'U/XC?%3QK)J$?AKPCI$MC;WNI?V3I=YK6IR"XU
M*ZLK"WAL=*T^\OKB:YNH8XX+=R6S@'.4I*32?;HNQ#D^;E2OM;J]C^_OP?\
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M_#O&L> MQ Z9VE0?;&>U?SK?\$FO&NJ^-_\ @K'_ ,$X[G4K'P[I<6A?M$_
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MH?@NZN-+\0:-.[I;:II[O)'-)87>QI+.Z:%(KN K<6S2P.DC>H:'_P $+?\
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M%A>7GA?7+FV$L4237"R:MJNHWF^ZDFD1KIH8W6".*-"6O+_B5BC^I"BOR?\
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M^F:7X L4=VP/,N-6\96(BB4F1TCFD"F*&9E3UEI_,OS5_P!1?\O/Z['ZG_\
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M[O\ T+/^#=QU?_@C+^PXR,& \&?$A"1_>C^.?Q11U^JNK*?<&OB/X>M=3?\
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MT[M_&VJ7+WNJ:E^PS\$+#4KJ1S))/J'AKQ%X"\,7LC.69B3<Z-+G<Q88PQW
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M7Q!X<LEN(9(R_P!MOYW)202B7\!O^"*WQB?X&?\ !57]A?QN;BTM++4/V@_
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M\'V5[XCFTJQ!6QL+O5H?L]Y?6UDA,=G'>2SBTB)BM_+C^2OHSX/_  ;^%OP
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MR^*?AQJMSXF\-W>HRKR=0U+PSXON]-MFDYFL/":1Q_+8O7YM_P#!K!8SW?\
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MX^T:]U28JO(BM],M[RXF?[L<,4DC?*IH?Q_./Z!_R]C_ (H?I?\ &Y_I"_\
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MG0:U5U?H^G5V76][]+?,_?X_\$=O^"6Q))_8._9IR22<?#710,GG@", #V
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MT7P'\:/BGIOA^ZF9][NFEZQXFUY-+1A\@M-#DTNQB3_4VL;$L?M[]D__ ()
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M2>'KC4X[>+4WT:YOH)+K3EU&.SLUOXK6:**]^QVAN4E:U@,?DOPF_P"":7[
M/P*\>:'\4?@_^R#\!?A[\1/#+W$OAWQEX;^'VB66OZ'/=VTME<7.DWYMWEL+
MN2TGGM_M5L8[E(II4255D<'_ "C/&_\ P5H_X*2>,O&GB[Q@_P"V_P#M1:3)
MXJ\2:QX@?2]#^-GC_1]&T[^U+Z:YCT_2M*TS7+33M.TVPA>*SL+&RM;>UM;2
M"&""&.*-5'^BG_P;1?'SXQ_M$?\ !+;P=XZ^.GQ(\7_%;QMIGQ@^+WA9?&?C
MS7=1\3>*;O0]+UFRO]-L]2UW5KB[U+4%TXZK<VMFUU<2O;V*6UG&1#;Q(HI)
MO1:_+R_X *2E=*^BN[Z+=+OW]-OD?NIX[\!^"OBAX.\1_#WXC^%/#_CGP+XN
MTNXT3Q1X1\5:39:YX>U_2;M0MQI^JZ3J,-Q9WMM)A6\N:)@LB)*FV2-'7\W]
M1_X(D?\ !)O5+V+4+S]@O]GUKJ%E>,V_A:>Q@#*XD7=:6.H6UI(-P&5D@92/
MD(*$K7^6KXQ_X*8_\%#_ !+XAUR[U?\ ;;_:EO9[W6-2N)(Q\</B)# ))[V:
M0I;V=MK\5M;0JS;(;:VAB@@C"Q0QI&JH-;3/^"B7_!3[X/:II^KVW[7O[8?@
MB_>2&]L6U?XJ?$^SM[\1-OC9]/UW4VL-6LVP1);W-K=V=Q&6CFBDC9E,\\7N
MK_=_7]?<N=:_%;O;_@];'^R-X;\.:!X/\/:%X2\*:-IGASPQX8T?3?#_ (=\
M/Z+96^G:/H>AZ/9PZ?I6D:7I]JD5M8Z=IUC;P6EG:6\<<-O;PQQ1(J( -JOY
M5_\ @W$_X+=?$O\ X*(V7CS]F']J:YTC5?VC/A1X37QYX;^(NF:=;:&WQ5^'
M,.KZ?H>KR^(=)LA#I$'C3PIJNMZ-%<W&B6FGVFN:)J,%XVE0WVDZOJ&H?LI_
MP5H_:=\0_L=_\$YOVM/V@O!>JIHGCWP;\*=5T[X>:PT4<\FD>/O&EU9>"?"&
MLVT$P:WGN]$USQ#9ZU:PW*2VTLVGHES!<0EX)+335^GY%+7;J?H'J^D:5X@T
MG5-!U[3+#6M#UO3KW2-9T?5;2WU#2]6TK4K:6SU'3=2L+J.6UO;"^M)IK6\M
M+F*2"YMY9(9HWC=E/YU-_P $=_\ @ELS,Q_8._9IRQ+''PUT51DG)PJQ!0,]
M   .@ %?Y7T'_!5S_@IA;ZQ%KJ_MZ?M9OJ4-^FI"67X[_$66)[I)Q<9DM9=>
M>TEB:08>VD@>V>,F%X6B)0_Z\_[)_P 6I?CW^R_^SM\;;B6*>[^+/P2^%_Q$
MOYH8TBADU'Q=X+T;7-1:**-52./[=>W 2-%544!550  E)2Z;?UO\A1DG>U]
M+7Z?KW7Y'RQ_PYU_X):_]&'?LU?^&VT;_P"-U+!_P1\_X)=6T\-S#^P?^S0)
M;>6.>(O\,M"E021.LB%XIH9(I5#*"T<J/&XRKHRD@_Q[_P#!TG^WA^V)\$/^
M"AWA+X7_  0_:5^-?P;\"Z+^SWX'U8>&OAA\2/%7@?2;_6]?U_Q==:EK6I67
MAS4].AO]4GBALK(WEVLTZV=C:VZ.L42H/VK_ .#6S_@H=\2?VS_V0OBA\+_C
MY\2O$GQ0^-W[.OQ'BMSXK\::M<:[XKUOX4>/M,34?!D^L:WJ$T^J:S>:1XCT
MGQOHK7M_---%I4&A6IF<1 *77-RVV]/+;^N@[ZM7::2?E;2UG??5:6Z>1_1Q
M\0O@]\*OBS\-]6^#WQ,^'?@[QS\*]=TNTT35OA[XF\/Z;JOA&]TK3WMI=.L9
M-"NK=[!(--FL[.?35BAC.GSVEK/9-!+;PNGPQ<?\$;/^"6%RH67]@[]F_:"2
M/*^'NFVYY&#EH#$QXZ9)QU&#7\'W_!?_ /X*&_MO> /^"LO[3_@'X9?M5_'[
MX8^ OAWJ7PYT/P;X*\ ?%;QGX2\,Z!#'\*/!%]?W&G:/H.K6%E!=ZMK-[J.L
MZA<^2UQ<7M_,[RLHC1/W+_X+-?%#]M6+_@AS^P%^V+\&?VAOCCX$\:^%O"/P
M-U/]H+Q7\.OB!XF\(:GXQT3XO_#70M(;Q)XXN_#FH:=-K#Q?$1/#D,5S?/,L
M>H^*;J0IYM^\@+IWTOR^FW7\OP0<R5]7IJ_N3TU\O+9?+]QKC_@AE_P2.N96
MFF_8*^ QD?&XIHNKPKP !B.'68XUX SM49/)R233[/\ X(:_\$D+"[M;ZV_8
M*^ JW-G<17,#3:'JEU$)H)%DC,EM=:Q-;3H'4%H9XI89!E9(W0E3_--_P:G_
M /!4/]H?XT?M%?'#]DW]ISX[_$/XS+XO^'$'Q0^$=[\5O&.M^,M;T+7? >IQ
MV/C'P_X>U7Q!>WE['9:]X?\ $=OKEWI(GDBC;PG)?6<-ONU22XO_ /!UU_P4
MR_:)^!OQ\^ 7[*W[-'QY^(OP<32?AC<?%CXK7/PJ\8ZOX-U?5]6\7^(=1T7P
M?H.O:KX?NK'4I+?2-(\+7FNQ:4]T+-U\16-]-!+*MJ\*O&W-96]%?>PN96YK
MNV]^N_KJ[^?F?W,:;ING:-IUAI&D6-GI>DZ596NFZ9IFG6T-EI^G:=8P1VME
M8V-G;I';VEG:6T45O;6T$<<,$,:11(J(J@K^*C_@AM\%_P#@I_\ MI?L2S_'
MSQ!_P45_:3\(V'B#XQ^.](\(VWB/QWJ?BBYU7PWX=TKPEI<NL6>H^*-/\1:@
MFGOXHA\2Z;';17L-FESIEU-#:I)/-/<%4FWTT?FMM/\ -_=YE*S2=[7L]5WM
M_F_N\S]#?^#H[]A:Z_:N_P"">E[\9?!FCMJGQ1_8^U>\^*NG0V=D]SJ6I?"_
M58;+2_BUI<#0@RI#IFCVNE^.[DL)(A;>"[E-B/,)H_X$?^"3/[>.M?\ !.;]
MN7X/?M'P2ZC-X&M=2;P5\9="TZ1Q+XB^$7BV:UL_%]F+8,(KV\TA8;+Q5HEM
M<!HFU_P_I3YC9%EC_P!C35])TS7])U30M;L+75=&UK3KW2=7TN^A2YL=2TS4
MK:6SO["\MY0T<]K>6DTMO<0R*R2PR.C@JQ%?Y'W_  7#_P""8WB'_@F=^V;X
MK\(:-I5ZW[//Q8O-6^('[//B1DGELSX4O+Q9]4\ W-[)OWZ[\.-0O4T"[2:9
M[N\T<Z#KLH4:PJ)$T[J2_I]&9RTM);K[K?UY=3_6O\'^+_#'Q \)^&O'7@K7
M=,\3^#_&&A:7XF\+^(]%O(=0TC7-!UNRAU'2M5TV]MWD@NK*^LKB&XMYHG9'
MCD4@U>U[7M$\+:)K'B;Q-K&E^'O#GA[2[_6]?U_6[^UTK1M$T;2K66^U/5M6
MU.^E@LM.TW3K*":[OKZ[FAMK6VAEGGE2)&8?Q%?\&O/_  5<5O&,?_!*[QKK
M_BGXF^&+33-9\4?LL?$R7PS>V=SH^G:7X</C#X@_"_Q39K<7\VD>&-(NX?$.
MI>"-=OYFA65;G1IY;6#5/#FG6/\ 65^WI^R#H7[>'[*7Q;_98\1_$'QK\+]+
M^*>BV^G2>,_ EV(-8TRXL-0M=4LTO;%Y8+?7_#MW=V<-MXB\-W5Q;6^N:3)<
MV#7=H\J74-IW5U]WGV_X)?\ 7]?\#3LVB?\ 9B_;S_8]_;*\-:AXK_9J_:$^
M&OQ3T[1[W4;#6[+1?$%M:>(]#FTVXDMYI=;\)ZL=/\3:18W C%UINHZAI5O8
M:I820WVGW-S:RK*?X7O^#O/]LSX$?M _&_\ 97^ ?P=\:^&/B)KO[-VB?&35
M/B?XA\(:SI_B'1=%\0?%>[^&5MI_@@ZMI<MS8MKNAV?PVGO_ !%90W<SZ?+K
M&GV%XEMJ%I=VZ>6?%#_@T;_X*<?#WQ+>1?!OXD_L]_%/PO<321Z?K>G?$/Q1
M\.O$)L//*0_\)#H'B'PG!8V5P8B)I;?2?$OB*W4!PMRTFV-OOO\ 87_X-)_B
MK-XU^'OB[_@H_P#&WP+K_P -OA_<0W^G? ;X.:KXEU^^\16K:F^KW?A3Q?\
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MSPX4\1:/%K.F7>BZJNG:G>W-Y<6C7^DW][IUS)"Z22V=W<V[-Y<TBM_E5_\
M!83/_#TK]OC<<G_AJ+XL\_\ <SWF/TI2322?=O3T7^3_ !\R9*T;7OK?;R>G
M7_@G^C9^S]\._ .B?\&Z/A?PC/X-T+5O",O_  2^\0^)-8\-75C!'I^MZMJW
MP%UGQEK-_>)%%E-4U3Q)=7.M2ZK$HOX=7F&J03)>QQS+_G$?\$PO%_B?6/\
M@J%_P3YUW7?$6M:QJMA^U;^R]H5MJ>KZG>ZE?0:#X>\=^#/#>AZ*EU>333KI
M.C>'+"RT#3-.$@M+#1+.UTNUBBL;>&!/]+?X'H'_ ." ?@Y" 0W_  2MNTP>
MF&_9DOQ@^V#S7^8?_P $T+H67_!1']AJ\)P+;]K+X 3Y]/+^*'AEOZ54OBBK
M=OSV_!ER=G3U^T_PY?+_ #]#^A/_ (/)/^3_ ']FS_LT#1?_ %<WQ?K]BO\
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MU45==K)+\S_/\_X.0+D7?_!:C]MV42B;9K?P5MMX((!LOV;/@W9F+@#F P&
MCJ#&022":_O\_P"#=FWMH_\ @C-^Q&8K6U@^U>$/B1-=""WAA%U.?C;\3+=[
MBX$2*)[B6*&))IY0TLH1?,9L5_GW?\'$_P#RF<_;C_['#X9_^J(^%E4OV5_^
M"_?_  4Z_8W^#'P^_9[^"'QE\):7\(?AA#J=KX1\):_\(/AEXC-G8ZQKVJ>)
MM0LKC7M0\--XEO()]9UG4KH/-K)N85N3!!<1P10QQPFHRDWY_F0FE*5W:[W^
M;[:G^N2JJBJB*J(H"JJ@*JJ. %4   #@ # K_& _X*>?\I'/V[O^SN?VA/\
MU:?B>O\ 5R_X)0?M6?$3]MW_ ()[_LU?M0_%G2=!T7XB_%/PKX@N_%5GX8M+
MJPT&74/#?CKQ5X-34].L;RXNY[.+6;7P[;ZN]K]IE@@GOI8[5OLJP@?Y1O\
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M<16"7U].+*.>>>:.U\I))I7#2,XNZZZ)7N4FGL_S/H"O\R?_ (.Z]<U'5/\
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M97ACX9VEXUO??&[]H;P'HEW;K*J&]\-^"=+\0^.=2C*;A)(L>O:3X4E954H
M"9"/E5_YP?\ @TQ_9I\8_%+_ (*3O\?+;2;I?AY^S9\+_&VJZ]XBDAG73AXN
M^(>CW'@/PKX9ANEC:%]7O[#6?$6MK:NR@:7H&H3,RO\ 9TE^_/\ @]!^+T=Y
MXT_8:^ MI-B30/#/Q@^+6N0JY(E_X2O4_!WA#PP\D8^5'M%\(>*]A)W,E^W
M4 M2_AO3K]Z=E_F-:0^3_%V7YG\2OA?PU?>+=7CT33KWP]I]U)9ZG>K<^*/$
M_AWP?I"Q:5IMUJEQ%)KGBG4](T>*\N(+.2#3+&2]6\U?4I+72M,@N]1O+6UF
M_P!9;_@W;^+ ^+?_  1^_8^O9;LWFH> _"WB;X3ZB[2B4PGX=^-?$&@Z/:9R
MQ06GAB'0H%B8@QHBJH5-H'^=I\:?V51X/_X(T_L1_M6#2Q%<_$_]K;]J;PO>
MZI]FV/<:4NA>!-#\-0FY\E3,@U+X0>.A&K3,D;6TPB!?[0(_Z]O^#./XW?\
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MO,GC!IM-QMOI?\/^"5)IN"33M)O371\O:_9W/V__ .#R3_D_W]FS_LT#1?\
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M+*Q52O,?\'JL\@U/_@G); CRGL?VKIV&/F\R*X_9UC0@]@%F?([D@]A7H_\
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M=+^)*>#/[8LKZQ?Q/X5N=/N;.X\#:3/97L%[=1LDMW!-9$R13P]'_P $9_\
M@CKH'_!(CP-\;?#.G?'35OCGK'QP\1>"]=UG5;WP+:> =/T&#P/IFOV&F:=I
MNF0>)_%EQ>//)XEU*>\U"YU* 2*MI#%80&&66X**+*][:]]?3T#SLKOK;4_:
'6BBBF!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ny20068427x1_ex5-1img01.jpg
<TEXT>
begin 644 ny20068427x1_ex5-1img01.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "= A8# 2(  A$! Q$!_\0
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M?@+_ +$OPM_Z8[&O\;NOTML?^"QG_!3S3;*STZQ_;0^,EM8V%K;V5G;1ZEI
MCM[6UB2"W@C!T<D)%#&D:Y).U1DD\U_.'!7%6#X9GF4L7A\3B%C8X14_J_LK
MP^KO$.7/[6I3^)5ER\M]G>VA_KE](OP3S_QDH\(TLBS7)\K?#U7.YXEYL\:E
M76:0RJ-%4/J>%Q3O3> J>T]IR?'#EYO>Y?\ 5+HK_*^_X?,_\%1_^CU_C/\
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M_P!8WB$XO_@T?_Y*)^V__P!B7\#/_3Y\3:_MPK^(_P#X-'_^2B?MO_\ 8E_
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M%\7?V$/&>J;;3Q.EU\;O@HMS(BJFOZ7:6>E_%/PI;,[---/JNA6_A[Q?I5A
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M]:C[#XOU/Q3+9P6_BGQ%HEU?>%;+PM+=Z!9WNLZIKFI?\(O^%7_!#O\ 8_\
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M-E\7>)M%\-QZA):ZW\2&NH[%]9O;);M[99X&G2W,C0K-$9 HD0G^SG_AH_\
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M2ERSC&7*VFD[6;3[!1115&(4444 %%%% !1110 4444 %%%% !1110 4444
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M3*EALOGB)T'2PE;%5H56\3.I4]I-XJ2DN;EM&-DG<****]T_- HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\
MI!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X
M?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_
M /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7
M_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^
MD&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_
M #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@
M#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##
M>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5
M_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\
M=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F
M\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P##
M#>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&
MW_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y
M\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_
M **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\
M^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__
M /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!
MM_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\
MA]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/
M_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5_
M_P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=
MO^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #
M_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O*
M /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW
M@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_
MP5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?'
M;_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO
M*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\
M,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_
M  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__ )O* /W_ **_ #_A
M]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_  PW@_\ ^;R@#]_Z
M*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\ I!M_P5__ /##>#__
M )O* /W_ **_ #_A]Y\=O^D&W_!7_P#\,-X/_P#F\H_X?>?';_I!M_P5_P#_
M  PW@_\ ^;R@#]_Z*_ #_A]Y\=O^D&W_  5__P###>#_ /YO*/\ A]Y\=O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG;17FGZC8W4+/#<VEY:317%O/&S)+%(CJ2"*4E9^70J+NO/J:M%%%2,_*/\
M;I_X*M_#[]A?XM^'?A)XK^$_C'QWJ/B+X<Z1\18=7\/:WHFFV5M9:OXF\7>&
M8]-E@U)&G>ZAG\(W-T\J'RFBO($4;XY*]H_8,_;S\)?MY>$O'OBWPEX"\1^
MK?P%XCTSPY=VGB/4],U.:_FU+3&U..YMI-,58XHHD4Q.DH+ESN'%?SL?\'"O
M_)Z'PQ_[-@\%_P#JUOC57W=_P;J?\D8_:,_[*?X5_P#44EJW%*-];V3^^Q*;
MYFNB7^1_1;1114%!117\^/\ P6%_X*A:]\!I[C]E_P#9U\0G2?BU?Z9#<?%'
MX@:<R'4?AOHVLV<=UIOAKPU<'=]A\<:YI=S#JEUK2H+GPKHEYIUSHLJ>(-3@
MU'PXTFW9";25V?HC^U9_P4P_9-_9"FNM#^(7CJ3Q1\0[8+O^%OPW@M/%/C:U
M9T61!KD;7^GZ%X4)CD@G2#Q3KFCW]U:SQW6G65]$2:_%KXB_\'%OC&>]N8?A
M+^S7X9TK3HWV6FH_$7QKJFOWMX@F5OM%SHWAK3?#<&FN\&Z+['%KVJB*;;/]
MNE3-L?Q!_9L_9;^/'[9WQ.F\$?"30;GQ/K\\AUCQ?XNU^]N+;PWX8M+^ZD,_
MB+QKXFFBO)+=;NY^T21Q1Q:CKVM7$=S'I.FZI>))$/Z/_@O_ ,&]'P3T33;.
M\^/7QB\?>/?$)6":ZTGX>0Z3X%\)VTK1J;BP>YU;3_%/B+6K>*7<D.I077A:
M:X0+(^FVS$Q+=H1WU?\ 73;[R+REM9+^OZV/C"+_ (.(/VF!+&9_@A\"Y(1(
MAFCB'C^&62(,#(D<S^+YTBD9,JDC03+&Q#-%( 4/T[\*?^#BGP;?75K9?&W]
MG3Q#X=MB42Z\1?#/Q?8>*_F;AI5\*^)=/\*26\,9PSA?%=_,T98QQO(BQR_7
MEW_P0B_8)N;:6"'2_BSI\L@ 2\M/B/,]S 0RL6B6_P!(O;0E@"A\ZUF7:S%5
M5]KK^?/[3'_!OAJ^AZ-?^(_V4OBI?^,+NPMY[A?AO\61I%AKNJK"CR"#1/'>
MAV6D>'YM4N"%@MK#6_#GA_37D/FW'B&T0[ >X^EOO_1_UU'[_=/[O\D?T'_L
MZ?M:_L^?M7>')_$?P+^)&C>,H[!(CK>A8N=)\6^'7E)1%U[PMJT-GK>G122J
M\-M?O9MI=^\4ATZ^O(T+U]'5_FT^"/'7QE_9;^+UOXE\)ZEXG^%?Q;^&VOW%
ME=0RPW&EZOI6J:9=F#5?#WB+1[V-4N[*:6"2PUO0-7M9["_M_-M+^TFA=D/]
MVG_!/S]L[P]^V[\ -(^)=M;V6B^/-"NO^$5^*GA.S:86^@^,;2VAN'NM+2YD
MFNF\.>(;*>#6="FEFNC!%/<Z-/>W6I:-J#A2C;5;?D.,KZ-6:_K^D?<5%%%0
M4%>6_&/XV?"K]G_P+J?Q)^,?C?1/ 7@S2<)/JVM3N'NKMTDD@TO1].M8[C5-
M=UFZ2*4V>C:-97^J78BE-O:2+%(5].EEB@BDGGDCAAAC>6::5UCBBBC4O)))
M(Y"1QQH"SNQ"JH+,0 37^?\ ?\%#?VU/&'[:7Q\\1^+;G5;^/X5>&-1U'0?@
M]X0:26#3=&\)VUP8(M<FT\D(?$WBT0)K6OWUP)KU'GM=$CN/[)T72[6VJ,>9
M^74F4N5'[D?&?_@X?^&^BW]]I7P&^!'B3QY;Q&:"W\6_$/Q';>!].DEC.V.\
MM/#&DZ=XGU74-/F(+Q+J&K>&M0,6TSVEM*S11_)DO_!Q!^TP99#!\$/@7'"9
M',,<H\?S2QQ%B8TDF3Q? DLBIA7D6"%9&!98HP0@A_89_P""&OBCXZ^"?#OQ
M=_:0\::W\*_!?BRPM-9\,> O"EE8O\1]7T&^5+BQUG5]4URUO]%\'1:E9-'>
M:782Z'XCU*>TNX;C4;;1Y(_L=Q^L-K_P0C_8)M[>*&72?BQ?21H%>[NOB1.E
MQ.<D^9*MEI-G:ASG!$%M"F ,(#DFO<72_P"/ZV^[T%[[UNEY?TG^)^>'@'_@
MXO\ &MO=0Q?%']F?POJ]D^U+B]\ ^.]6\.75KF0EKB'2_$6C>*8K[;%A%LWU
M?3MTF93?(H\D_M)^R5_P4Q_94_;%N8?#OP\\77OA?XCR027!^%WQ%M+7PYXP
MNHX(WEN'T$P7^I:#XJ6&*&>ZE@\.:UJ6I6EA"][J>G:? &*_F/\ '#_@WE^%
MFHZ+>WW[.WQF\:^&/%$-L\MEH/Q732/%7A?4[M!B*S.M^&M$\.:WX=MI@,R7
MTFG>+98Y-Q6R:)U2'^:'XG_#'XN_LO?%_5? GCC3]=^'7Q3^'&NVMS%<6-[<
M6&H6%]9RQ:AH?B?PQKVG2PO+:7*K:ZOX>\0:3<A98FM[RTG211L.6,MM'_7?
M]&*\H_%JN_\ 5OQ1_I+45^87_!*+]M74OVR_V<%OO'%S#<?&'X5:G;>"OB1<
M1K#"WB%9;/[9X7\<&SMXXX+,^)=/BNK6_AB5(7\0Z%KUQ:6]I836EK$5#5FU
MV--S^$2O]-#P/_R)?A#_ +%?P_\ ^FFTK_,OK]@=._X+C_MYZ5I]AIEIXA^&
M0M=.LK6PMA)\-]-=Q;V<"6\(=S> NXCC4,Q +')/6M)1;M;S_0RA)*]^MOZ_
M$_MWHK^)3_A^M^WW_P!#%\,/_#:Z9_\ )E'_  _6_;[_ .AB^&'_ (;73/\
MY,J>27E]_P#7])^5ZYX^?W?U_2?E?^VNOQ)_X+[?\F-:1_V7CP!_ZCGCROQ*
M_P"'ZW[??_0Q?##_ ,-KIG_R97SM^T[_ ,%-/VI?VN?AQ!\*_C'JW@N]\)6W
MB;2_%D4.@>#[/0KX:QI%IJ=E9NU[!<2N;=8-6O!)!MVR,T;$CRQD4'=/31I_
ME_7R!S33WU7]?UY/RO\ 1/\ P0I_Y/[\._\ 9,/B5_Z;+.O[:Z_B4_X(4_\
M)_?AW_LF'Q*_]-EG7]M=*?Q/Y?D@AL_7]$%%%%26%?S_ /\ P7R_:D'P]^"'
MA3]F;PUJ7E>*?C;>1^(/&<=O*Z7-A\,?"FHQ3V]O-Y;QR1+XM\76UI;0.&DA
MNM.\,>)-/N8C'<J3^^]Y>6FG6EUJ%_<PV=C8VT]Y>7=S(L-O:VEM$T]Q<SS.
M52*&"%'EED<A4169B ":_P ]']O/]I>[_:S_ &I_BG\85N+A_"][K+>'/AS:
M3^>@L/AUX7+Z5X6"VLY+V%QK%K%)XGU>R4F.'7M=U8IE7R:@KOTU_P OZ\B9
MNRMU?],_17_@@U^S/_PM']I;7?CQK^G"X\)? #11-HTDZ2&"Z^)GC&"\TO01
M$K*+>Z&A>'XO$FL3G>\NFZHWAJZ$0>:&:/TK_@X!_9A_X0[XL> _VI?#M@L6
MA?%BRA\">/9;>#8D'Q#\*:<SZ!J-Y,L:HT_B?P5:?8;:/<\N/ M[-(0)4K]T
M?^"8'[,K?LL_L=_#3P;JVGFP\>>,;9OBA\2(YK<VUY!XL\96UG<QZ/?1.BRQ
MW?A?PY;Z!X6NXW9Q]MT:ZF0JL^Q?3OVZOV;K7]J_]EKXK?!L0VS>(]5T)M<\
M W=R$ L/B!X9;^V/"L@N&9?L<.HW]L-!U.Z4EH]&U?4EV2K(T3OF]ZZVV^77
M_,7+[MNN^O?^M#\"_P#@WX_:D.B>+_B'^R3XFU$+IWC..Z^)_P ,(IRHV>*M
M'L+>T\=:';NSF6235_#-AIGB"UM41;>UC\)Z]=$B>^;S/ZK:_P UWX1?$SQE
M^SW\9/ WQ1\-)+IWC/X6>--.UZ"QO%DMB]YH=^!J6A:I$R&5+74K=+S1=6MV
M3>;2ZNH&4,2*_P!&#X3?$WPO\9_ACX"^+/@JZ-YX5^(GA/1/%VAR2&,7$5EK
M=A#>K97T<;R+;ZGITDKZ?JEF6,EEJ-M=6DH66%U!-:W[_I_2"#NK=5^1Z%11
M14%A7^;K^TS%K4/[2'[04/B02+XBB^-WQ7BU]95*2C6H_'FO+JHD1E1DD%\)
MPZLB%6R"JD8'^D57\J7_  6-_P""8GQ&D^)/BK]K;X ^&-3\;>&/&(36OB[X
M)\/VDFH^)/"?B.VM8X-3\;:1I%LCW^L^&-=BMX]3\11V,5YJ&@:PVJZS<1GP
M[=R/H-P>OJK?D1--JZZ=/4_<+_@FC\0?A[\0OV&_V;9OAWJ6F7EMX1^%7@OP
M#XKLK"2$7.B>/_"/A[3=*\9V&KV<;&:QU"ZUR*ZUM5NDBEU#3]6L=9B62TU*
MVGE^ZZ_S;O@S^T-\<?V=/$,WB3X*?$_QA\-=8G,*:B/#VJ2V^GZNEK(9(+;Q
M!H-P+C0]?MH)<LEGKFFW]LCDD0@DY_4/P!_P7H_;F\)".+Q4OPB^*40C6.:;
MQ9X$ET74'PP9IX9_A]K?@VPAN6 V$R:5<6H1FVV@?:ZC@^EK?B)35DG?16_K
M\S^TZOSM_P""DW["X_;M^#GACP-H^OZ#X-\<>#/&]KXH\.>+]<TZ[U"*STVX
MTV_TOQ'H16P(NUM=:CFTR\F2,A'O=#TR27(@6OR?\ ?\'&-F[0VWQ2_9?NH$
MWYGUGP!\1XKMMA" K#X:\1>&+(;U(D?>_BO#ADC\N,H99/T)^"G_  6L_83^
M,%W::3JOC7Q'\%];O'2&&T^,.@1:'I3SDX?=XN\/ZEXG\(Z=:J072[U_6]$1
MXBI=(IBT"+EDM;/Y:_D5>+TNM?Z_K\#YI_8%_P""/OQ?_8V_:8\)?'#5?C=X
M$\4^'M*T7Q?H/B+PYHFA>([#4M7T_P 0^'+^QLXH+B\E^QJ+/7_[%U29;E71
MX;"01J+CR77]_P"J&EZKI>N:;8ZSHFI6&L:1J=K#?:;JNEWEOJ&FZC97,:RV
M]Y8WUI)-:W=K<1,LD-Q;RR12QLKH[*0:OTFV]6-)+8****0PK\F?^"V__*._
MXL?]C1\*O_5C>':_6:OR9_X+;_\ *._XL?\ 8T?"K_U8WAVG'=>J_,4MGZ/\
MC^:O_@C/_P I)OV</^ZP?^J%^*-?W=5_"+_P1G_Y23?LX?\ =8/_ %0OQ1K^
M[JJGNO3]63#9^OZ(****@L**** /\\W_ (*%_P#)\O[6'_9>/B/_ .I'>U_8
MW_P25_Y1W?LR_P#8L>*O_5C^,Z_CD_X*%_\ )\O[6'_9>/B/_P"I'>U_8W_P
M25_Y1W?LR_\ 8L>*O_5C^,ZTE\$?E^3,X_'+Y_FC]%Z***S-#X0_X*=_\F"?
MM2_]DPOO_3GIE?Q3_L):%HWBC]LK]F;PWXBTNQUO0-?^,O@;1M;T?4[:*\T[
M5=)U/6K:SU#3KZTF5X;FTO+2:6WN()%9)8I'1@037]K'_!3O_DP3]J7_ +)A
M??\ ISTROXO/^">G_)\O[)__ &7CX<?^I'95K#9^OZ(B6\/7]4?0'_!4+_@G
MOK/[$OQ8&K^$[;4-3_9^^)&H7MU\.M>F$MRWAG43YEY>_#?7[UFD?^T]'M]\
M^@WMXXE\1>'XC=I)<ZCI>OK9_;W_  1<_P""DG_"M-<TG]D7XX^(63X=^)]1
M^S_!KQ9J]WFW\#>*=3N"W_"#ZA<SMBV\*>*K^9FT28N(=#\3W)MY8_[-UZ:[
MT;^G#X_? ?X<_M*_"?Q=\&OBGI']K>$?%]@;:9X##%JNBZC"WG:5XB\/WD\%
MRNGZ]HEZL5[IMX8)HA+&;>[M[JQN+JTG_@+_ &OOV4OB)^QQ\;?$?P<^(,1N
MULS_ &KX-\6P6DUII/CKP7>SSQZ-XGTM)7E$)G%O-9:OIRW-V=%UVRU/2&N[
MO[&MW.)J2L][?T_7OW$TXOF6W5?U_73U_P!%BBOP?_X(Y?\ !25?V@_"-C^S
M5\;/$7F_'/P)I.SP7XBU><F\^+'@C2K? 6YO9G)U'QYX2LXA'K)F8:EXCT&.
M#Q(QU/4;'Q9J$7[P5FTT[,M.ZNNI_')_P<*_\GH?#'_LV#P7_P"K6^-5?=W_
M  ;J?\D8_:,_[*?X5_\ 44EKX1_X.%?^3T/AC_V;!X+_ /5K?&JON[_@W4_Y
M(Q^T9_V4_P *_P#J*2UH_@^4?T)7QR]/\C^BVBBBLBSRSXX_%32/@=\&_BA\
M8==C%QIGPU\">)_&<]F9?);4I-!TFZO[32(9=K[+G5[V&WTRU;8W^DW<0P<U
M_G/ZWK'C[X\?%?4-:U%[WQ=\3/B[X[ENIA$A>]U_QEXVUSY+:UA!(5[[5M12
MVLK6/$<*O#;0JL2(H_M6_P""UOBVY\+_ /!//XM6=HTD<OC+Q!\-O"3S1KEH
MK:;QUHFNWJE_/B\N.ZL] GL)6\NYWQ7;P^0OF_:;?^7S_@DMX(M/'W_!0O\
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MO_@DK_RCN_9E_P"Q8\5?^K'\9U_')_P4+_Y/E_:P_P"R\?$?_P!2.]K^QO\
MX)*_\H[OV9?^Q8\5?^K'\9UI+X(_+\F9Q^.7S_-'Z+T445F:'PA_P4[_ .3!
M/VI?^R87W_ISTROXO/\ @GI_R?+^R?\ ]EX^''_J1V5?VA_\%._^3!/VI?\
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MN(+>\N+*1KFWDTS7;#1]<M9X%,AFTW[*S"WN[@-^NU)VN[;#5TE?>P5_"O\
M\%2_V ?%?['_ ,:M>\5>&- OKK]GCXD:Y>ZU\/\ Q)96CR:7X3OM5FFO[WX:
M:U+"ACTJ^T&9KB+PQ]K8+K_AB&TNK6XNM2L/$%KIG]U%<_XK\)^%_'?AS6/"
M'C7PYHGBWPIX@LY-.UWPWXDTNRUK0]8L92K/::EI>HPW%E>0,R(_ESPNHD1)
M% =%8.,N5@TFOR?8_AZ_87_X*R_'G]B[2[?X?3Z=8_%WX*17<EU:_#_Q)J-Q
MI>I^%GNYVN-0/@7Q9#;:A-H=M?S.]U<Z-J.F:YH(O'N+VPT[3;_4-3O;S]U/
M!/\ P<!?L;Z]:VP\8>#?C=X"U-D_TQ)O#/AOQ+HT$GERN1::EHGBQM4NXMT:
M0B2;P]82&6>,F 0K--%6^//_  0*_9=^(^HWVN?![QEXV^ FI7\DLK:+:PP?
M$+P':RR;W,EAH&NW^E^);0-.Y=[6/QS_ &=%"%M=/L=/B1<?S]?'O]@#_A1_
MB*30/^%L_P#"3[+^ZL?M?_"!_P!BY^S6UG<>;Y'_  F>K8W_ &O9L\X[?+W;
MVW[5KW)/JF_ZOU7],A<ZTT:^7_ 9_1%XN_X+[?L3:%922^'-$^-?CC4#%FWL
M],\%Z+HUL9SY@6.\OO$?BO2WMX@44RS6MEJ#JLJ&."9A*L?X5?M]?\%:OC!^
MVIHS?#71?#\/P?\ @G]NAO=0\'Z9K<^MZ]XUN+&=)]-D\;>(A9Z3!=Z997,,
M6I67AK3]+M=-M]3$-UJ-QKMWINDWMEYY^SO_ ,$]_P#A?GBRW\,?\+=_X13[
M1?P6/V[_ (0'^W=GG65_>>;]F_X371MVW[#Y>S[0N[S=^\;-K_T)_L^?\$'/
MV4OA3J>G^(OBQKWBW]H+6]/=)4TKQ!%;>#_AY)<Q;7BN+CPEH=S>:O?[)5W&
MPU?QCJ>C7,1^SW^EWD1D$A[D7U;7]>2'[[T=DNO]7?Z'Y2?\$3OV%/%GQ:^-
MOAW]J/QQH5WIGP=^#VIOK/@^\U*VE@C\?_$RQ\R+1(]#$BQM=:1X(OS_ ,)!
MJFLP.;>/Q#INC:'"+QY-:72_[':SM'T?2/#VE:=H6@:5INAZ)H]E;Z=I.C:/
M8VNF:5I>GV<2P6EAIVG644%I965K"B0V]K;0Q001(L<4:HH T:AN[N4E96"B
MBBD,*_)G_@MO_P H[_BQ_P!C1\*O_5C>':_6:OF+]L#]F/0OVO\ X$>)_@1X
MD\4:MX/TGQ-J7AK49]>T2SL[_4;5_#6OV&O01Q6U^5MG2YFL$MY2YRD<C,GS
M 4UHUZH3U37=,_CB_P"",_\ RDF_9P_[K!_ZH7XHU_=U7XN_LF_\$7_AE^R;
M^T#X _: \/?&GQWXMUCP#_PE7V/P_K/A_P /V.FZA_PE7@KQ)X*N/M-U8R-=
M1?9+7Q'/>P^4#ON+:*-_W;N:_:*G)INZ["BFE9]_T04445)04444 ?YYO_!0
MO_D^7]K#_LO'Q'_]2.]K^QO_ ()*_P#*.[]F7_L6/%7_ *L?QG7R!\=?^"%?
MPH^.GQD^)OQDU;X[?$/0M3^)OC77_&E]HVG>&_#=S8Z9=:_?S7\UE:7%S(+B
M:WMWF,<4DP$C* 6YS7ZN?LP_ 72/V8?@1\//@1H6OZCXHTGX>:=J6G66O:O;
M6UGJ.HIJ6OZMK\DEU;69-M$T4VK26Z"(D&*%&/S,U7*2<4NJM^1"BU)OH[_B
MTSWJBBBH+/A#_@IW_P F"?M2_P#9,+[_ -.>F5_%Y_P3T_Y/E_9/_P"R\?#C
M_P!2.RK^\G]HKX+Z9^T3\$?B1\$M:UJ_\.:7\2/#DWAR]US2[>WN]0TV&:XM
M[@W-K;W9%M-*K6ZJ$F(0AB3R!7Y)? K_ ((5_"CX%_&3X9?&32?CM\0]=U/X
M9>-= \:6.C:CX;\-VUCJ=UH%_#?PV5W<6TAN(;>X>$1RR0@R*I)7G%7&22:=
M][_D3)-N+71Z_>C]UJ***@H*_E@_X+5?\$V?[ NM=_;,^!>@?\234;IK[X^^
M#=(ML?V-J5W(H;XK:390+M.EZI<N%\?0VZ+)I^IS1^+I([BRU'Q-?Z/_ %/U
M3U'3M/UC3[_2-7L++5-*U2RNM.U/3-1M8+[3]1T^^@DMKVPO[*YCEMKRRO+:
M66WNK6XBD@N())(I8WC=E+3L[B:NK?TC_,3K^LO_ (-U/^2,?M&?]E/\*_\
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K-INJZ'>S%?TW*JJJJJA54!550 JJ!@*H&      , <"BH;NV^Y:22LC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Mar. 25, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001891101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BRC Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Mar. 25, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Class A Common Stock,
$0.0001 par value per share<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred Stock, $0.0001
par value per share<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Subscription Rights<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 43,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 6,041.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">(1)</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> There are being registered
hereunder such indeterminate amount of Class A common stock, preferred stock,
warrants to purchase common stock or preferred stock, subscription rights to
purchase common stock, preferred stock, units and other securities and units as
may be sold by the Registrant from time to time, which together shall have an
aggregate initial offering price not to exceed $500,000,000. The Registrant
will determine, from time to time, the proposed maximum offering price per unit
in connection with its issuance of the securities the Registrant is registering
under this registration statement. The securities registered also include such
indeterminate number of shares of Class A common stock and preferred stock as
may be issued upon conversion of or exchange for preferred stock that provide
for conversion or exchange, upon exercise of warrants or pursuant to the
antidilution provisions of any such securities. In addition, pursuant to Rule
416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the
shares being registered hereunder include such indeterminate number of shares
of common stock and preferred stock as may be issuable with respect to the
shares being registered hereunder as a result of stock splits, stock dividends
or similar transactions.<br/><br/>The proposed maximum
aggregate offering price per unit will be determined from time to time by the Registrant
in connection with the issuance by the Registrant of the securities registered
hereunder and is not specified as to each class of security pursuant to pursuant
to Item 16(b) of Form&#160;S-3&#160;under the Securities Act. The proposed
maximum aggregate offering price has been estimated solely for the purpose of
calculating the registration fee pursuant to Rule 457(o) under the Securities
Act of 1933, as amended. </div> </td> </tr> </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Class A Common Stock,
$0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-270727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Mar. 30,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred Stock, $0.0001
par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-270727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Mar. 30,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=9', window );">Offering: 9</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Subscription Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-270727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Mar. 30,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=10', window );">Offering: 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-270727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Mar. 30,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=11', window );">Offering: 11</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-270727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Mar. 30,  2023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=12', window );">Offering: 12</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 456,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-270727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Mar. 30,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 50,278.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">(2)</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> The Registrant previously registered the offer
and sale of securities having a maximum aggregate offering price of $500,000,000
pursuant to a registration statement on Form S-3 (File No. 333-270727)
initially filed with the Securities and Exchange Commission on July 18, 2025
(the &#8220;Prior Registration Statement&#8221;) and, in connection therewith, paid a
filing fee of $55,100. Of such securities, an aggregate of $461,500,000 remain
unsold (the &#8220;Unsold Securities&#8221;). Pursuant to Rule 415(a)(6) under the
Securities Act, the securities registered pursuant to this registration
statement include the Unsold Securities, and the filing fee of $50,857.30 associated
therewith (which amount is based on the filing fee rate in effect at the time
of the filing of the Prior Registration Statement) is hereby carried forward to
be applied to the Unsold Securities and no additional filing fee is due with
respect to such Unsold Securities in connection with the filing of this
registration statement. Pursuant to Rule 415(a)(6), the offering of the Unsold
Securities pursuant to the Prior Registration Statement shall be deemed
terminated as of the date of the effective date of this registration statement. </div> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdFormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., "Form S-3" in the human-readable and "S-3ASR" in the XBRL).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdFormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:formTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrevslyPdFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrevslyPdFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFctvDt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFctvDt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule415a6Flg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is claiming a 415(a)(6) carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule415a6Flg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=9">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=9</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=11">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=11</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=12">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=12</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Mar. 25, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">6,041.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 6,041.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>13</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="ny20068427x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ny20068427x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ny20068427x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ny20068427x1_ex107.htm">ny20068427x1_ex107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="75">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20068427x1_ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "ny20068427x1_ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 3
   },
   "contextCount": 13,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 75,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20068427x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20068427x1_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20068427x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20068427x1_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20068427x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20068427x1_ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-26-011145-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-011145-xbrl.zip
M4$L#!!0    ( !6)>5QGV!B5.A4  )S_   6    ;GDR,# V.#0R-W@Q7V5X
M,3 W+FAT;>U=ZU?;.!;_[K]"DYW9@5.2V,X[T.RA 0I3H)1 .],]^T&QE42#
M'\$/DLQ?OU>RG=B. ^;5)L9SSA3'EJ[N^_XDV_+>?Z:ZANZ(95/3>/^[5!)_
M1\103)4:P_>_[_>Z)R>__Z<C[/U2+**/Q" 6=HB*^C/4-?5Q3Z'HRL*&/3 M
M'6TY^C8JHI'CC-OE\F0R*2G0QE:H16S3M11BLQ.H6/3)=2W"B+71-Z!XABTD
MUY!4;TMB6Y;1]547R:)<7VH>'OLR(+R#3D^[R#30&?S_67&05$%2JUVIM>5*
M0*KFD1HY("_(;-AMG[WW!9_E)'8+?EN5+-I-^Y96LHE2&IIW9;A09M2#AH.!
MFMP0+D0:4MNLRE)CWI@IC'<PK2$T%"MEO\6\PW156PG:&AHUR)\?+D\7S9WD
M]HNF92<P'G; _(P]L2C*14D.$2F" !%"@4#WT9%J1;%9K$@!'6AY<X^D['(?
MVR1H[MI%9S8F]KS+ -M]WCRX$E$E(Z;&[./3KI>]B^&F]#Z=&[:##67.R52[
MI_&?I\#WHF5<QDF%-Y5:K5:97YTWM9/: 4FI_.?9:4\9$1T7ESBQZ>-[K>:'
MQ4&A(Z"]$<$J_$5[#G4TTD%[9>] 0,*>3AR,%--PB '.Y)"I4^;]>) 7R:U+
M[]X7NM[UXA78I5"&$"O[)/?ZICKK[*GT#MG.3"/O"P-H6AQ@G6JS-KJB.K'1
M.9F@2U/'QB[B5VWZ#VDC21X[NP7>MR,PYLKL:&]D!93ZIJ42J^B8XS:JCJ?(
M-C4*N4'#RLTN\B_V3<<Q]38R3(/,3VIDX,1.670XFI\;$>^7/)[N(AU;0VJT
M41-&P*YC[J()59T1\">*O^V"L&'AF'J*6*-#Z,!)!OV# <12H\;% H'0GCW&
M1D0OON1B281&H'7-M-KH7R+_SU?.Q&>N;VHJT#F<CFB?0K83&WME1J^S4%5,
M<R$^?:8"[4A\./\DUZ=W)BR. O8E5DK.DSC=ZW>Z6%-<C2<(9 [0$86(&*(C
M0M 5[FO$WBOW.\E2) F1R-T]K-W#6*03IZL2Q;0XIVW7  ]A>:[0.6)%;H].
MV^ HYZY.+*IXL3%U+LG@?4$1"\C .AMYH+9[;E^GMFU<C0N(0DF@T[MBI5&%
M$=-28.-%>]<*G5ZQLE>.4.@L_^9*#.DSK?Z>X)>%SA;7"PO^[6>9#\7M5>C\
M^U]27=Q-X],KW"&-JJ& MP\-R'FS2S*D-BMESCE<62A>KA<ZK^I9'RZ[Z,10
M2LN6B]OV=2UY.,6 G9CP+$(7ZD#81KTQ4>B  @"C!J*.C;HC;,%@SS1Z8H9,
MZPJI/>%E$BZ*FQ#-;0AC\"R&I#:K:-K,UQZQ0&'84%$76]8,0:A,L*6B'E%<
MBSJ49;W$O!W[;W[5X8-$:R 04""5@O98R?)/@C0:'ML@7W TU[57 8MB2>:Z
M#E>T!,4#+I@7W: V\H%"3=EO<'A'#1KZ-%N_S2T'J$)-:"$]V"(%C8>)-/(6
MSVT!&+\3<@68,3I4P5H0:@ </&>9$QIC50W<$M5*5>9KOG,&A@N=XIW:'HP+
M.S$+21_5Q8?T $R4S3 #KS%8,BI*UN2SQI]K#X PDGBHPI\&_\.B[U'\)>2^
M6+'R$]*,U_$%:GA)C29))+^V.%T-VS;,-&!"L_E2,:P<0=%6K*Q<NC]2S%=T
MQWW== %V+&IH)J2ZL,RQ:?/%KBG571U]'@P U<$LZ *P'4$7Q$+7!G4R(6P@
MX_YP:)$A=DA,VK47$DU&U"$<71&V.#"Q\#AUF%Z"P"LE_%&5\9G1%YH"\'0#
M<FVL2-$\.9^Q9D2>O;Y5[AQ1F!G /+%/K(R(=0*YD&(-'4+B4!QZ1]#!?6'U
MDHGCE9-C:/'KPB)WU'1MF#)>8,IGUUW3,)C $',3ZHR@)@#GX4DCH&W4)[SX
MLPFYKZ^88AA@1^D0.ZB"=7U?D*J%5W.5)ZIJ:3:]-'=^C,#SY5W)XQXX&UJ0
M[=2 66O8WY+%Z@Z2*TWXIU;;7C6M6:XPKQE0$;X91VPYX-X%+JF O#LR;!'+
M:0_HE*C% =;879;%(B-S/_"]"_5(&X:7&NN\CG%/^T"X9ZY8BGKA.,S0O&O9
M9O=;:V&4 "GU%&<670%N%#J'MR[,;!*LL:XXZF74 %.XL"*:4"SXW&Z?W0W6
M(57V'%.YV1%^%4NB*$H@@87NL.82- 98;8^P1;*KL^5 =RPW$N=L:EBM-<Q8
MF+<*'3B[96YOL&Y>8_DGYS?G]R?S^S.Q>IS'G,579/%GS%MB-V_NY33%RO]R
MO=I P"P_!S WQ1PP_U#4(Z<"S$TIXX!YM1JB@+DIL_5G M?Y')IC9>1C9>'M
M8.7$&$^'E9N5'"OG_.;\KB._&X#R<A9SK/S6EJ KST+4U1Q1_U!L5$F'J&N%
MSF=GQ&XR;BP*>IH68H"Z7NCTW+ZM6'3,;]5=LC'L[&KER;BYD>/FG-^<WW7D
M=P,07\YBCINSL\9<?18B;N:(^(>BGFHZ1-S*-B)>K84H(FZ)A<XW;+$7QK(*
M@Q/#-QT,;DDY#,[YS?E=1WXW ,#E+.8P^*TM']>> Y9;<@Z6?R@VJJ4"RZU*
MML'R:BW$P'*UT&'O^F45*2?&;DJD7,N1<LYOSN\Z\KL!&"]G,4?*V5DPKC\+
M V_$6WQ;TO:F &#A 5.E < -!ORPIID*W\YT"U @VWX5:]NH-R+:8(-!3^1E
M7HTX#@GM3F4P-]:6-M$J.B.JW!C$MMN(>B]\+[?QY5IYW1=Q?GV@F7B^HZ-*
M[;&&9^PRVZH+_4+UL6DYV/"22E.6Y-WUWXWB,> [,6FD!-_-''SG_#[ [Z^^
M\QU9V-NF(.Y]$)H4@MU^7S@Y/XHZH^'J1=7DT<N:A#WR#$_WAT,G2)ULFY@"
MLH%'N"X6D O1S4=P;37LL>P=ULI.HR;NB*(8>&W VB:Y[>MH%0  VXTF49-C
MUPKM<UD5Q4+'>R6DTI0V6I6/\%#Y,9K<UYV'7;(J2H5.?4>L2J5F,X46-V Z
MD+/X5B95#^Z@LC%W'.;S*SX%BN^S\_/G/1NV]N\CY0TJ CG'.<<YQR_-\=*^
MSYLV>UFISI^[.]X:PIK-8FH-T-43\-0&;,'WP-[UC]I_;_/0XRKI<P3YDDN6
MC32+YU51SOAV'JO5$'E\I"I6\OWO0CI+N=HMU7 ]LMQ=%:N%#IS>PMM;]7S%
M^Q4W#%]S!M=:H1E W)O%;^H,W1U,U/AGNJIB\F>Z-BB;/$K^"\MB6X^?]\,J
MJ!<ZE4JE*#?$AMS(KB;"=4?%#BE"(79&117/BC."K215*<[=@1-650-45:Z(
M[(.6/]AGGI70T6,?Q\E!_9L#]<UTH+Z9<5"_6@TQ4-_*]^CSU/5D/"^).9[/
M\?R:*S3'\^N5;1[ \Y*493R_)'\2GI?D-X#GFR^"YZ7*&\'S^5)^COH3XZB5
M"O5+U6R_"+I:"U'0+]7>TCZ"K>=@^WJ.[7-LO^8*S;']>F6;A[!](\O8?DG^
M1&S?? /8OO4RV+[U1K!]CMK?'&J7Q%2P71:S#=OO44,4M\M2YG<[9+IX,EJ7
MY1RMYVA]S16:H_4U2S</P'6YDF6XOJR )+PN5]\ 7H^7GB<"=KGV1@![OAB?
MP_KD0$KU8?FJ7,\XK$_Y8?FJW,CVOHQ2^J_%)V#Z9H[I<TR_Y@K-,?V:I9N'
M,'TKTYA^20%)F+XBO@5,+[T(IJ](;P33YV@]Y?Z1<C;VCY12?=*^6I'S#23S
M#21?.57+SY@E5"KY+"&?)3QZ4S[F<S]PW\AJA;WZ7:OOR.N]<60^G5FSO/C
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M;&%"@7"@>!@X@1?&[=@RQZ8-Q'0\I;JKQT=D>UHS:07**ZE!O*(ZH0X8%G1
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MZ00X2F$R%#(9KS7<0Z'_&#PVT-_#C#%I62]7XRKPJ-MC#5Q]Q_\%F1&,:JC
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M'7YJ?I+-G!PV?X X8^*2R,"!>-V33U%OB'>>#U6.C14:'V93U%1CXX,HEG,
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I,# V.#0R-W@Q7V5X,3 W+FAT;5!+!08      0 ! $0   !N%0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ny20068427x1_ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>9</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>10</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>11</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001891101</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>12</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-25</startDate>
            <endDate>2026-03-25</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c0" id="ixv-374">S-3</ffd:SubmissnTp>
    <ffd:FormTp contextRef="c0" id="ixv-375">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-26">BRC Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c1" id="ixv-376">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c1" id="ixv-377">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c1" id="ixv-378">Class A Common Stock, $0.0001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c1" id="ixv-379">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="c2" id="ixv-380">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c2" id="ixv-381">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c2" id="ixv-382">Preferred Stock, $0.0001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c2" id="ixv-383">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="c3" id="ixv-384">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c3" id="ixv-385">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c3" id="ixv-386">Subscription Rights</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c3" id="ixv-387">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="c4" id="ixv-388">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c4" id="ixv-389">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c4" id="ixv-390">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c4" id="ixv-391">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="c5" id="ixv-392">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c5" id="ixv-393">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c5" id="ixv-394">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c5" id="ixv-395">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="c6" id="ixv-396">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c6" id="ixv-397">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule457oFlg contextRef="c6" id="ixv-398">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric contextRef="c6" decimals="INF" id="ixv-399" unitRef="usd">43750000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c6" decimals="INF" id="ixv-400" unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c6" decimals="2" id="ixv-401" unitRef="usd">6041.88</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="c7" id="ixv-402">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c7" id="ixv-403">Class A Common Stock, $0.0001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="c7" id="ixv-404">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="c7" id="ixv-405">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="c7" id="ixv-406">333-270727</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="c7" id="ixv-407">2023-03-30</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="c8" id="ixv-408">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c8" id="ixv-409">Preferred Stock, $0.0001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="c8" id="ixv-410">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="c8" id="ixv-411">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="c8" id="ixv-412">333-270727</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="c8" id="ixv-413">2023-03-30</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="c9" id="ixv-414">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c9" id="ixv-415">Subscription Rights</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="c9" id="ixv-416">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="c9" id="ixv-417">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="c9" id="ixv-418">333-270727</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="c9" id="ixv-419">2023-03-30</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="c10" id="ixv-420">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c10" id="ixv-421">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="c10" id="ixv-422">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="c10" id="ixv-423">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="c10" id="ixv-424">333-270727</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="c10" id="ixv-425">2023-03-30</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="c11" id="ixv-426">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c11" id="ixv-427">Units</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="c11" id="ixv-428">true</ffd:Rule415a6Flg>
    <ffd:CfwdFormTp contextRef="c11" id="ixv-429">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="c11" id="ixv-430">333-270727</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="c11" id="ixv-431">2023-03-30</ffd:CfwdPrrFctvDt>
    <ffd:OfferingSctyTp contextRef="c12" id="ixv-432">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule415a6Flg contextRef="c12" id="ixv-433">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric contextRef="c12" decimals="INF" id="ixv-434" unitRef="usd">456250000</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="c12" id="ixv-435">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="c12" id="ixv-436">333-270727</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="c12" id="ixv-437">2023-03-30</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee contextRef="c12" decimals="2" id="ixv-438" unitRef="usd">50278.75</ffd:CfwdPrevslyPdFee>
    <ffd:TtlOfferingAmt contextRef="c0" decimals="INF" id="ixv-439" unitRef="usd">500000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="c0" decimals="2" id="ixv-440" unitRef="usd">6041.88</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="c0" decimals="0" id="ixv-441" unitRef="usd">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="c0" decimals="0" id="ixv-442" unitRef="usd">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="c0" decimals="2" id="ixv-443" unitRef="usd">6041.88</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c6" id="ixv-346">&lt;table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 99%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0px 0pt;"&gt; &lt;div style="margin-bottom: 4pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(1)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0px 5.4pt; text-align: left; font-size: 10pt;"&gt; &lt;div style="margin-bottom: 4pt;"&gt; There are being registered
hereunder such indeterminate amount of Class A common stock, preferred stock,
warrants to purchase common stock or preferred stock, subscription rights to
purchase common stock, preferred stock, units and other securities and units as
may be sold by the Registrant from time to time, which together shall have an
aggregate initial offering price not to exceed $500,000,000. The Registrant
will determine, from time to time, the proposed maximum offering price per unit
in connection with its issuance of the securities the Registrant is registering
under this registration statement. The securities registered also include such
indeterminate number of shares of Class A common stock and preferred stock as
may be issued upon conversion of or exchange for preferred stock that provide
for conversion or exchange, upon exercise of warrants or pursuant to the
antidilution provisions of any such securities. In addition, pursuant to Rule
416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), the
shares being registered hereunder include such indeterminate number of shares
of common stock and preferred stock as may be issuable with respect to the
shares being registered hereunder as a result of stock splits, stock dividends
or similar transactions.&lt;br/&gt;&lt;br/&gt;The proposed maximum
aggregate offering price per unit will be determined from time to time by the Registrant
in connection with the issuance by the Registrant of the securities registered
hereunder and is not specified as to each class of security pursuant to pursuant
to Item 16(b) of Form&#160;S-3&#160;under the Securities Act. The proposed
maximum aggregate offering price has been estimated solely for the purpose of
calculating the registration fee pursuant to Rule 457(o) under the Securities
Act of 1933, as amended. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c12" id="ixv-359">&lt;table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 99%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0px 0pt;"&gt; &lt;div style="margin-bottom: 4pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(2)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0px 5.4pt; text-align: left; font-size: 10pt;"&gt; &lt;div style="margin-bottom: 4pt;"&gt; The Registrant previously registered the offer
and sale of securities having a maximum aggregate offering price of $500,000,000
pursuant to a registration statement on Form S-3 (File No. 333-270727)
initially filed with the Securities and Exchange Commission on July 18, 2025
(the &#x201c;Prior Registration Statement&#x201d;) and, in connection therewith, paid a
filing fee of $55,100. Of such securities, an aggregate of $461,500,000 remain
unsold (the &#x201c;Unsold Securities&#x201d;). Pursuant to Rule 415(a)(6) under the
Securities Act, the securities registered pursuant to this registration
statement include the Unsold Securities, and the filing fee of $50,857.30 associated
therewith (which amount is based on the filing fee rate in effect at the time
of the filing of the Prior Registration Statement) is hereby carried forward to
be applied to the Unsold Securities and no additional filing fee is due with
respect to such Unsold Securities in connection with the filing of this
registration statement. Pursuant to Rule 415(a)(6), the offering of the Unsold
Securities pursuant to the Prior Registration Statement shall be deemed
terminated as of the date of the effective date of this registration statement. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-446">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-447">0001891101</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-448">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-449">N/A</ffd:OffsetTableNa>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
